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Abstract
Employing Exoglycosidase And Transferase Enzymes in Capillary Nanogel
Electrophoresis for the Determination of N-glycan Linkages and Enzyme
Michaelis-Menten Constants.
Lloyd Bwanali
As a post translational modification protein glycosylation plays a crucial role in protein
signaling, binding, kinetics and folding. In disease diagnosis and prognosis, monitoring
glycosylation has been identified as a biomarker. Sialylation and sialic acid linkage in Nglycans are markers of cancers including liver, pancreatic and kidney cancer.
Quantification of sialic acid linkage is analytically challenging because of the diverse
linkages and the presence of heterogenous branching. A capillary electrophoresis
method is reported that integrates a unique combination of enzymes and lectins to modify
sialylated asparagine-linked glycans (N-glycans) in real time in the capillary so that Nglycan structures containing α2–6-linked sialic acid are easily separated, detected, and
quantified. N-glycans were sequentially cleaved by the enzymes at the head of the
separation capillary so that the presence of α2–6-linked sialic acids corresponded to a
shift in the analyte migration time in a manner that enabled interpretation of the N-glycan
structure. Complex N-glycans from α-1-acid glycoprotein were analyzed using this
approach, revealing that a limited number of α2–6-linked sialic acids were present with
biantennary, triantennary, and tetraantennary N-glycans of α-1-acid glycoprotein (AGP)
generally containing 0 or 1 α2–6-linked sialic acid. The capillary electrophoresis method
quantified the sialic acid linkages using nanoliter volumes of enzyme and lectins.
Conversion with enzyme was in real time and incubation and separation occurred in less
than 40 minutes.
In biotherapeutics glycosylation of IgG is a critical attribute, and modification of the
glycosylation will influence the IgG efficacy. Glycosyltransferases have been employed
to modify this glycosylation. Capillary nanogel electrophoresis was utilized to create
discrete regions for an online galactosyltransferase reaction and subsequent separation
of substrate and product. The β1-4 galactosyltransferase enzyme, donor, and co-factor
were patterned in the capillary. The substrate was driven through these zones and
converted to galactosylated products which were separated and identified. The degree
of glycosylation was discernable. The method was applied in establishing the MichaelisMenten value, KM of the enzyme. Additionally, the method was adapted to transfer
galactose residues to protein. The applicability of the method for real-time online
modification of whole protein was demonstrated with the Herceptin glycoprotein. The
method demonstrated the applicability of capillary electrophoresis to characterize
glycosyltransferases. This method is compatible with low enzyme or substrate volumes
and is fast and automated.

Acknowledgements
I would like to acknowledge my research advisor, Dr. Lisa A. Holland for the outstanding
mentoring during my Ph.D. studies. I will always be grateful for the opportunities she
afforded me during the graduate studies, which will continue to be an invaluable asset in
my career. Her belief that we can always go one step further, will always push me on.
Thank you, Dr. Holland, for helping to give me the necessary acumen for my professional
development. It is my hope and prayer that you remain steadfast in your commitment to
furthering chemistry graduate research at WVU.

I would like to thank the rest of my graduate committee: Dr. Harry O. Finklea, Dr. Stephen
J. Valentine, Dr. Peng Li, and Dr. Kathleen Brundage for your advising efforts during my
graduate career.

Your investment in terms of time, patience, and insight into my

dissertation is greatly appreciated.

I would acknowledge and thank the National Institute of Health who provided funding
through grant number R01GM114330.

Lastly, I would like to acknowledge my lab mates (past and present) : Cassandra Crihfield,
Srikanth Gattu, Gayatri Gautam, Vincent Nyakubaya, Courtney Kristoff, Lindsay Veltri,
Grace Lu, Tyler Davis, Patrick Russo, Ebenezer Newton and Marriah Ellington. Thank
you for the assistance, support, and teamwork. You made my graduate career more
navigable.

iii

Dedication
"We are like dwarfs sitting on the shoulders of giants. We see more, and things that are
more distant, than they did, not because our sight is superior or because we are taller
than they, but because they raise us up, and by their great stature add to ours." John of
Salisbury

To my parents Fredrick and Alice Bwanali. You always believed we can “see more, and
things that are more distant.” To Chrissylee Bwanali for the faith and strength. I also
dedicate this dissertation to my brothers and sisters, Memory, Wellington, Regina,
Taonga and Aaron. You were a great source of inspiration, support, love, and motivation.

To Alexander Matidaise Bwanali and Alden Munashe Bwanali for telling me: “Dad you do
the coolest stuff in the world. When we grow up, we want to do what you do.”

iv

Table of Contents
Abstract ............................................................................................................................ii
Acknowledgements ......................................................................................................... iii
Dedication .......................................................................................................................iv
Table of Contents ............................................................................................................ v
List of Figures ................................................................................................................ viii
List of Tables ...................................................................................................................xi
List of Symbols/Nomenclature....................................................................................... xiii
Chapter 1 Introduction and Background on Glycosylation Modification and Analysis with
Capillary Electrophoresis ................................................................................................. 1
1.1 Introduction ............................................................................................................ 2
1.1.1 Glycosylation significance. ............................................................................... 2
1.1.2 Advantages of capillary electrophoresis in glycosylation analysis. .................. 2
1.1.3 Dissertation overview. ...................................................................................... 3
1.2 Background ............................................................................................................ 3
1.2.1 From monosaccharides to glycans. ................................................................. 3
1.2.2 Capillary electrophoresis as a tool for glycan analysis. .................................... 7
1.2.3 Sialic acid detection and quantification .......................................................... 19
1.2.3 Biological reagents for asparagine-linked glycan analysis in capillary
electrophoresis ....................................................................................................... 26
1.3 Conclusions ......................................................................................................... 33
1.3 Acknowledgements .............................................................................................. 33
1.4 References........................................................................................................... 34
Chapter 2 : Quantification of the α2-6 Sialic Acid Linkage in Branched AsparagineLinked Glycan Structures with Capillary Nanogel Electrophoresis ................................ 45
2.1 Introduction .......................................................................................................... 46
2.2 Materials and methods ......................................................................................... 49
2.2.1 Chemicals and reagents ................................................................................ 49
2.2.2 Preparation and derivatization of standards................................................... 50
v

2.2.3 Preparation of enzymes. ................................................................................ 50
2.2.4 Preparation of lectins. .................................................................................... 51
2.2.5 Capillary electrophoresis................................................................................ 52
2.2.6 Statistical analysis. ........................................................................................ 55
2.3 Results and discussion ........................................................................................ 55
2.3.1 Serial enzyme processing to determine α2-6 linked sialic acid. ..................... 55
2.3.2 Quantifying α2-6 linked sialic acid in a triantennary asparagine-linked glycan
standard. ................................................................................................................. 56
2.3.3 Verification of serial enzyme processing........................................................ 58
2.3.4 Working range of specific sialidase................................................................ 60
2.3.5 Measuring the α2-6 sialic acid content simultaneously in a mixture of
asparagine linked glycans. ..................................................................................... 64
2.3.6 Working range of specific sialidase for an asparagine linked glycan mixture. 69
2.3.7 Enzyme processing. ...................................................................................... 73
2.3.8 Comparison of the α2-6 sialic acid content from different sources of α-1 acid
glycoprotein. ........................................................................................................... 73
2.4 Conclusions and future directions ........................................................................ 82
2.5 Acknowledgements .............................................................................................. 83
2.6 References........................................................................................................... 84
Chapter 3 : Capillary Nanogel Electrophoresis for the Determination of the β1-4
Galactosyltransferase Michaelis-Menten Constant and Real-Time Addition of Galactose
Residues to Glycans and Glycoproteins........................................................................ 90
3.1 Introduction .......................................................................................................... 91
3.2 Materials and methods ......................................................................................... 96
3.2.1 Chemicals and reagents. ............................................................................... 96
3.2.2 Preparation and derivatization of standards................................................... 97
3.2.3 Preparation of enzyme and lectin. ................................................................. 99
3.2.4 Capillary electrophoresis.............................................................................. 100
3.3 Results and discusion ........................................................................................ 105
3.3.1 In-capillary asparagine linked glycan processing and separation. ............... 105
3.3.2 KM determination of pentasaccharide glycan standard. ............................... 108
vi

3.3.3 Evaluating the addition of galactose residues to asparagine linked glycan. 116
3.3.4 Application to glycoprotein. .......................................................................... 123
3.4 Conclusions and future directions ...................................................................... 128
3.5 Acknowledgements ............................................................................................ 130
3.6 References......................................................................................................... 130
Chapter 4 Conclusions and Future Directions ............................................................. 137
4.1 Introduction ........................................................................................................ 137
4.2 Future................................................................................................................. 139
4.2.1 Serial enzyme sequencing ........................................................................... 139
4.2.2 Real-time in-capillary transferase reactions. ................................................ 141
4.3 Future directions ................................................................................................ 157
4.4 References......................................................................................................... 157
Appendix ..................................................................................................................... 160

vii

List of Figures

Figure 1.1 Six representative structures of D conformer monosaccharides .................... 4
Figure 1.2 . N-glycan core structure and main classes.................................................... 5
Figure 1.3 Diversity in asparagine linked glycan structures due to different monomers,
linkages or branching. ..................................................................................................... 6
Figure 1.4 Illustration of with main components of capillary electrophoresis. ................. 7
Figure 1.5 Illustration of charge distribution in the capillary when the pH is above 4. .... 9
Figure 1.6 Conceptual diagram of separation of mixture of analytes with capillary
electrophoresis. ............................................................................................................. 10
Figure 1.7 Electropherograms of Immunoglobulin G asparagine-linked glycans obtained
with nanogel. ................................................................................................................. 14
Figure 1.8 Schematic of the reaction for the reductive amination labeling of asparaginelinked glycans................................................................................................................ 16
Figure 1.9 Effects of 2-aminobenzoic acid reaction conditions on the peak area. ......... 17
Figure 1.10 Electropherogram showing the separation of α2-3 and α2-6 linked sialic
acids in asparagine-linked glycans. ............................................................................... 23
Figure 1.11 Electropherogram of asparagine-linked glycans with α2-3 and α2-6 linked
sialic acids from human plasma. ................................................................................... 24
Figure 1.12 Illustration of exoglycosidase enzymes and the glycosidic bond they cleave.
...................................................................................................................................... 27
Figure 1.13 Illustration of a glycosyltransferase reaction where monomer is transferred
from donor to acceptor. ................................................................................................. 29
Figure 2.1 Conceptual diagram of quantification of α2-6 sialic acids in a sample with
both α2-3 and α2-6 sialic acids...................................................................................... 48
Figure 2.2 Illustration of in capillary reaction showing that presence of α2–6-linked sialic
acid is related to galactose residues following processing with serial enzymes ............ 53
Figure 2.3 Concentration range of α2-3 sialidase for triantennary asparagine-linked
glycan. ........................................................................................................................... 61
Figure 2.4 Online serial enzyme sequencing of α-1-acid glycoprotein sample 1. .......... 65
Figure 2.5 Establishing the working range of α2-3 sialidase enzyme concentration for α1-acid glycoprotein sample 1......................................................................................... 70
viii

Figure 2.6 Establishing the working range of α2-3 sialidase enzyme concentration for α1-acid glycoprotein sample 2. ........................................................................................ 74
Figure 2.7 Analyses of α-1-acid glycoprotein sample 2 asparagine-linked glycans. ..... 78
Figure 2.8 Identification of glycan and contaminant peaks in Figure 2.7. ..................... 79
Figure 3.1 Conceptual diagram illustrating the online reaction where the transferase
enzyme adds a monomer to an acceptor biantennary glycan, pentasaccharide, that has
been end labeled with aminobenzoic acid. .................................................................... 95
Figure 3.2 Before and after cleanup samples of 2-aminobenzoic acid labeling reaction.
...................................................................................................................................... 99
Figure 3.3 Impact of manganese zone on biantennary N-glycan conversion .............. 102
Figure 3.4 The process of in capillary galactosyltransferase enzyme reaction............ 106
Figure 3.5 Determination of the Michaelis-Menten for the galactosyltransferase enzyme.
.................................................................................................................................... 111
Figure 3.6 Calibration curve used to establish relationship between concentration and
area. ............................................................................................................................ 112
Figure 3.7 The Michaelis-Menten curves showing reproducibility of method. ............. 114
Figure 3.8 Online modification of glycans recovered from Herceptin. ......................... 117
Figure 3.9 Confirmation of online modification of glycans recovered from Herceptin with
lectin. ........................................................................................................................... 119
Figure 3.10 . Flow injection analysis done by pushing APTS with 10% nanogel ......... 121
Figure 3.11 Online modification of glycan on intact IgG1 glycoprotein. ....................... 124
Figure 3.12 Establishing the amount of modification at different enzyme to substrate
ratio as evidenced by lectin retardation of modified Herceptin. ................................... 126
Figure 3.13 Confirmation that presence of enzyme in capillary caused shifting of
Herceptin peaks. ......................................................................................................... 128
Figure 4.1 Degradation of sialic acids dues to heat..................................................... 140
Figure 4.2 Online reaction employing α2-3 sialyl transferase to modify standard
biantennary asparagine-linked glycan. ........................................................................ 144
Figure 4.3 Online modification of standard agalacto biantennary asparagine-linked
glycan in 3-(N-morpholino)-propanesulfonic acid pH 7. .............................................. 148

ix

Figure 4.4 Online modification of standard agalacto biantennary glycan in 2-(NMorpholino)ethanesulfonic acid pH 6.5. ...................................................................... 149
Figure 4.5 Online modification of Herceptin asparagine-linked glycans in 2-(NMorpholino)ethanesulfonic acid pH 6.5. ...................................................................... 150
Figure 4.6 Modification of intact Herceptin glycoprotein when enzymatic conversion pH
is different to separation pH. ....................................................................................... 152
Figure 4.7 Separation of Alexaflour 488 labeled Protein G. ........................................ 154
Figure 4.8 Online labeling of Herceptin with Alexaflour 488 tagged Protein G. ........... 156

x

List of Tables
Table 1.1 Some glycosyltransferases and the monomers they add. ............................. 29
Table 1.2 Some lectins used in N-glycan analysis. ....................................................... 32
Table 2.1 Normalized areas for Figure 2.2B employed for establishing α2-6 linked sialic
acid in triantennary standard using multiple enzymes. .................................................. 57
Table 2.2 Raw areas for Figure 2.2B employed for establishing α2-6 linked sialic acid in
triantennary standard using multiple enzymes. ............................................................. 57
Table 2.3 Normalized areas for Figure 2.2C used to validate α2-6 linked sialic acid in
triantennary standard using α2-3 sialidase. ................................................................... 59
Table 2.4 Raw areas for Figure 2.2C used to validate α2-6 linked sialic acid in
triantennary standard using α2-3 sialidase. ................................................................... 59
Table 2.5 Comparison of triantennary glycan to internal standard areas across
instruments for each enzyme condition. ........................................................................ 60
Table 2.6 Figure 2.3 normalized areas of α2-3 sialidase working concentration range for
triantennary standard. ................................................................................................... 62
Table 2.7 Figure 2.3 and Table 2.6 raw areas of α2-3 sialidase working concentration
range for triantennary standard. .................................................................................... 63
Table 2.8 Peak area of α2-6 linked sialic from α-1-acid glycoprotein glycans. .............. 66
Table 2.9 Figure 2.4 normalized peak areas for α2-6 sialic acid structural assignments
using multiple enzyme in α-1-acid glycoprotein sample 1. ............................................ 67
Table 2.10 Figure 2.4 raw peak areas for α2-6 sialic acid structural assignments using
multiple enzyme in α-1-acid glycoprotein sample 1. ...................................................... 68
Table 2.11 Figure 2.5 normalized areas of α2-3 sialidase working concentration range
for α-1-acid glycoprotein sample 1. ............................................................................... 71
Table 2.12 Figure 2.5 raw areas of α2-3 sialidase working concentration range for α-1acid glycoprotein sample 1. .......................................................................................... 72
Table 2.13 Comparison of α-1-acid glycoprotein sample 1 glycan area to internal
standard area across instruments for each enzyme condition. ..................................... 72
Table 2.14 Figure 2.6 normalized areas of α2-3 sialidase working concentration range
for α-1-acid glycoprotein sample 2. ............................................................................... 75
xi

Table 2.15 Figure 2.6 raw areas of α2-3 sialidase working concentration range for α-1acid glycoprotein sample 2. ........................................................................................... 76
Table 2.16 Comparison of α-1-acid glycoprotein sample 2 glycan area to internal
standard area across instruments for each enzyme condition ...................................... 76
Table 2.17 Peak area of α2-6 linked sialic from α-1-acid glycoprotein sample 2 glycans.
...................................................................................................................................... 80
Table 2.18 Figure 2.7 normalized peak areas for α2-6 sialic acid structural assignments
using multiple enzyme in α-1-acid glycoprotein sample 2. ............................................ 81
Table 2.19 Figure 2.7 raw peak areas for α2-6 sialic acid structural ssignments using
multiple enzyme in α-1-acid glycoprotein sample 2. ...................................................... 82
Table 3.1 : Impact of manganese zone on biantennary N-glycan conversion ............. 102
Table 3.2 Line equations and errors for 3 sets of data used to achieve the calibration
curve. .......................................................................................................................... 112
Table 3.3 Areas used to achieve the Calibration Curve. ............................................. 113
Table 3.4 Reproducibility in substrate peaks for n=3 runs used for KM. ...................... 115
Table 3.5 Reproducibility in product peaks for n=3 runs used for KM .......................... 115
Table 3.6 Area distribution of substrate and product with changing enzyme
concentration. .............................................................................................................. 118
Table 3.7 % distribution of substrate and product with changing enzyme concentration.
.................................................................................................................................... 118
Table 4.1 Relative abundance by area of α2-6 sialic acid of heat treated α-1-acid
glycoprotein asparagine-linked glycans....................................................................... 141

xii

List of Symbols/Nomenclature
CE

Capillary electrophoresis

MS

Mass spectrometry

EOF

Electroosmotic flow

EPH

Electrophoretic mobility

AGP

α-1-acid glycoprotein

2AB

2-Aminobenzoic acid

ECL

Erythrina Cristagalli Lectin

AAL

Aleuria Aurantia Lectin

MAL

Maackia Amurensis Lectin

SNA

Sambucus Nigra Agglutinin

GAL T

β1-4 Galactosyltransferase

N-glycan

Asparagine-linked glycan

xiii

Chapter 1 Introduction and Background on Glycosylation
Modification and Analysis with Capillary Electrophoresis

The section “1.2.3.4 Other Approaches to Distinguish Sialic acids in Complex Samples
with CE” is Adapted with permission from Kristoff, C. J.; Bwanali, L.; Veltri, L. M.;
Gautam, G. P.; Rutto, P. K.; Newton, E. O.; Holland, L. A., Challenging Bioanalyses
with Capillary Electrophoresis. Analytical Chemistry. 2020, 92 (1), 49-66. Copyright ©
2019 American Chemical Society.
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1.1 Introduction
1.1.1 Glycosylation significance.
Glycosylation is a protein post translational modification which plays a crucial role in
protein signaling, binding1, kinetics and folding.2

Glycosylation therefore plays an

important role in many physiological processes.1,

3

It’s importance has been

demonstrated as monoclonal antibody glycosylation impacts efficacy4, 5 and acute phase
protein glycosylation is employed as a biomarker for disease diagnosis and prognosis.3, 6
In biotherapeutics, research has focused on how a particular type of glycosylation impacts
purification before monitoring efficacy7, how designer glycosylation can be achieved4, 8
and the motoring of batch to batch glycosylation.5 In disease diagnosis and prognosis,
glycosylation research has focused on monitoring changes in the glycosylation with goal
to detect and quantify these aberrations thereby linking them to disease states.3, 9, 10 New
tools are being developed to detect, quantify or modify glycosylation. Advances have
been made with capillary electrophoresis to meet these needs.

1.1.2 Advantages of capillary electrophoresis in glycosylation analysis.
Capillary electrophoresis (CE) offers several advantages which makes it an attractive
analytical technique for asparagine-linked glycan (N-glycan) analysis and modification.
High separation efficiency and high peak capacity is realized in CE making it ideally suited
for complex N-glycan analysis.11 Investigations in CE are usually fast and multiple
capillaries can be employed in a single instruments to increase throughput.12 Capillary
electrophoresis can be integrated with other techniques like MS 12-14 thereby increasing
the information that is achieved. Capillary electrophoresis is adaptable to carry out real

2

time reactions and analysis with minimal user intervention. Easy of automation and
consuming picolitre to nanoliter volumes of sample. Capillary electrophoresis is suited
for analysis with limited biological reagents.

1.1.3 Dissertation overview.
This dissertation is composed of a literature review of status of N-glycan analysis and two
manuscripts submitted to the Analytical Chemistry journal. Chapter 1 is a literature review
on the fundamentals and importance of glycosylation.

Furthermore, background

information on capillary electrophoresis, its use in N-glycan analysis and competitive
techniques is discussed. The chapter concludes by focusing on enzymes and lectins for
glycan identification and modification. Chapter 2 focuses on a cost effective in capillary
method that integrates a unique combination of enzymes and lectins to modify sialylated
N-glycans in real time. This approach enables separation, detection and quantification of
N-glycan structures containing α 2-6 sialic acids. Chapter 3 covers the employment of a
thermally reversible nanogel in capillary electrophoresis to create discrete regions for a
galactosyltransferase reaction to modify glycans and subsequent separation of substrate
and product.

1.2 Background
1.2.1 From monosaccharides to glycans.
Glycans are compounds that have multiple monosaccharide monomers are linked. A
monosaccharide is the simplest sugar molecule and cannot be hydrolyzed further into a
simpler sugar. Many monosaccharides exist, with the common ones existing as hexose

3

(six carbon sugar), deoxy-hexose (a hydroxyl group at the 6-position or the 2-position of
the hexose) or acetyl or amino substituted hexose.

The structures of the common

monosaccharides are shown in Figure 1.1. For easier representation, the Consortium of
Functional Glycomics has developed nomenclatures to represent monosaccharides. 15
For the 6 monosaccharides illustrated in Figure 1.1, this nomenclature is shown next to
the monosaccharide name.

Figure 1.1 Six representative structures of D conformer monosaccharides
Glucose, mannose, and galactose are common unsubstituted hexose
saccharides. Fucose has one less hydroxyl group and is termed a deoxyhexose sugar. N-Acetylglucosamine and N-acetylneuraminic acid represent
substituted hexose saccharides.
4

Monosaccharides link together through the glycosidic bond, and when several of them
are connected they form glycans. These glycans can be covalently linked to a variety of
biological molecules including proteins and lipids. When a protein has a glycan attached
to one of its amino acids, it is referred to as a glycoprotein. Linkage of glycans to protein
can be on an asparagine amino acid (N-glycans) or threonine/serine amino acid (O
glycans). N-glycan linkage is through the N-acetylglucosamine (GlcNAc) attaching to the
nitrogen atom on the asparagine through a β-1N linkage. The common feature of Nglycans is the mannose core as shown in Figure 1.2A. Attachment of other monomers to
the mannose core give rise to the complexity observed in N-glycans. Three main classes
based on these attachments are high mannose, complex and hybrid as depicted in Figure
1.2B.

Figure 1.2 . N-glycan core structure and main classes.

5

Complexity and structural diversity of N-glycans is further demonstrated by the presence
or absence of monomers, the linkage of these monomers, or the position. Linkage can
either be α or β, and which arm has the monomer can be different. Although a variety of
N-glycan structures can occur, the biosynthetic pathways of these molecules limit the
diversity of structures that are physiologically relevant.16 Figure 1.3A illustrates the
assortment that can be found in complex N-glycans with the addition of different
monomers. Figure 1.3B illustrates the two common positional isomers found for sialic
acids. The diversity introduced by branching is depicted in Figure 1.3C.

Figure 1.3 Diversity in asparagine linked glycan structures due to different monomers,
linkages or branching.
A shows variability by the presence or absence of monomers. B shows variability
introduced by linkage position of sialic acids. C shows variability due to branching.

6

1.2.2 Capillary electrophoresis as a tool for glycan analysis.
1.2.2.1 Basics of capillary electrophoresis.
Capillary electrophoresis separates analytes in a capillary based on their charge to size
ratio which is a result of two transport mechanisms. The main components of a capillary
electrophoresis system are the high voltage power supply, the capillary, the buffer vials,
the detector, and a signal processor as depicted in Figure 1.4. The high voltage power
source is used to drive analytes in the capillary past the detection window. The most

Figure 1.4 Illustration of with main components of capillary electrophoresis.
These components are the high voltage power supply, the capillary, the buffer vials, the
detector, and a signal processor.

7

common modes of optical detection are UV-absorbance and fluorescence, though
hyphenated techniques like CE-MS exist.

Transport in the capillary is either due

electrophoretic mobility or electroosmotic flow. Electrophoretic mobility is based on the
migration of the cations towards the cathode and the migration of the anions towards the
anode, under the influence of applied voltage. This migration of charged particle is
defined by the equation 1.1, where µ is the electrophoretic mobility, q the analyte charge,
η is the viscosity of the background electrolyte and r is the analyte radius.
µ=q/(6πηr)

(1.1)

Equation 1.1 shows that highly charged analytes will have greater electrophoretic mobility
if they have the same radius with analytes that have a lower charge. In contrast, for
analytes with the same charge, lower radius analytes will have a greater electrophoretic
mobility compared to those with a larger radius.

The second mode of transport is the electroosmotic flow, which is the bulk flow of the
liquid inside capillary. At a pH above 4, the capillary surface is deprotonated and will
have a net negative charge. This will result in positively charged ions forming a layer on
the capillary surface as shown in Figure1.5. In turn some anions in the bulk solution will
form a layer on these cations. When a voltage is applied these cations migrate towards
the cathode dragging with them counter ions in solution. This phenomenon leads to the
entire buffer solution moving towards the cathode. Electroosmotic flow is pH dependent,
and higher pH lead to higher EOF, as a consequence of the capillary surface being more
deprotonated.
8

Figure 1.5 Illustration of charge distribution in the capillary when the pH is above 4.
The density of the positive charges formed in the ionic layer decreases exponentially
with distance from capillary surface.

Apparent mobility in the capillary is the sum of the electroosmotic flow and the
electrophoretic mobility. When a separation is carried out in an uncoated capillary the
analytes pass the detection region in the order of cations first, followed by neutrals and
then anions. For analytes of similar size, the mobility is summarized by vectors as shown
in Figure 1.6.

9

Figure 1.6 Conceptual diagram of separation of mixture of analytes with capillary electrophoresis.
Each analyte is represented to show the corresponding vector for electro-osmotic flow,
electrophoretic and the net mobility. The sample mixture consists has five different analytes of
cations, neutral and anions with different charge to mass ratio. Reproduced with permission
from: Gattu, S.; Crihfield, C. L.; Lu, G.; Bwanali, L.; Veltri, L. M.; Holland, L. A., Advances in
enzyme substrate analysis with capillary electrophoresis. Methods 2018, 146, 93-106. Copyright
© 2021 Elsevier B.V .
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1.2.2.2 Suppressing the electroosmotic flow.
Capillary zone electrophoresis is when the separation is carried out in an unmodified
capillary and the two modes of transport detect analyte migration. Challenges with
capillary zone electrophoresis include analyte adsorption to the capillary surface, and
everything injected in the capillary ends up migrating towards the detector. Negatively
charged silanol groups on the capillary surface have been shown to interact with cations
and proteins through charge-charge interaction. This poses a challenge for in-capillary
reactions where analytes need to be passed through zones of enzymes or lectins. At
appropriate pH with suppressed EOF stationary reactions zones can be created in the
capillary allowing for real time modification of analytes. In-addition with suppressed EOF
only analytes of interested, i.e. either cations or anions, are migrated towards the detector
simplifying interpretation of the electropherogram. This is advantageous especially in UVVis absorbance where most analytes would absorb at the 200 or 214 nm wavelength
commonly used for monitoring peptides.

Several methods, including nanogel coating, have been used to passivate the capillary
surface and suppress the EOF.

Cationic, anionic, and neutral coatings have been

reported and some are available commercially.17, 18 The phospholipid nanogel coating
developed in the Holland lab offers several advantages.

The nanogel coating is

composed of 25 mM 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC) and 50 mM
1,2-dihexanoyl-sn-glycero-3-phosphocholine (DHPC) dissolved in the relevant buffer. To
make the nanogel, DHPC and DMPC are weighed into a vial and buffer added to get the
required concentration.

The solution is vortexed until the DMPC and DHPC are
11

completed dissolved. This is followed by three freeze thaws to ensure the DHPC and
DMPC as adequately mixed. The solution is vortexed and aliquoted into vials. The
aliquoted nanogels are frozen and have a lifetime of 10 days. The coating is neutral,
which makes it versatile for separation of anionic analytes in reverse polarity or cationic
analytes in normal polarity. The coating can easily be regenerated and is cost effective,
coasting lees than 5 cents per separation.11

1.2.2.3 Phospholipid Nanogel to Enhance Separation
Phospholipid nanogel fills are employed to enhance N-glycan separations.11,

19, 20

Phospholipids nanogel are thermally responsive allowing patterning in the capillary to
improve separations. The nanogels increase viscosity which translates to an increase in
frictional drag.20 Equation 1.1 demonstrates that when the viscosity of the separation
medium increases, the mobility decreases.

The change in mobility allows for the

separation of n-glycans with subtle differences in structure. Employing phospholipid
nanogels therefore allows for the separation of N-glycans.

The morphology of the

phospholipid assembly is temperature dependent. At low temperatures phospholipid
exist as nano disks and have low viscosity enabling introduction in capillary. When
temperature is increased nanoribbons are formed forming a gel like matrix. Phospholipid
nanogel have previously been used to improve the separation efficiency N-glycans and
resolve comigrating isoforms,11 as they increase the separation medium viscosity (which
translates to decrease in mobility). In one study, by changing the % composition of the
phospholipid nanogel used IgG N-glycans were resolved as demonstrated in Figure 1.7.
The goal of this research was to distinguish the bisected N-glycans which are known to
12

increase the antibody-dependent cell-mediated cytotoxicity.11

Three phospholipid

concentrations, 10, 15, and 20 %, were selected to improve separation resolution of comigrating peaks 6 and 7. Peak 6 is not bisected and peak 7 is bisected. At lower nanogel
concentration these two peaks were comigrating which made quantifying peak 7
challenging. It was demonstrated that with increase in the nanogel composition resolution
is improved.
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Figure 1.7 Electropherograms of Immunoglobulin G asparagine-linked glycans obtained with nanogel.
Separations in A are done at 10 % nanogel, B at 15 % nanogel and C at 20 5 nanogel. Separations were
obtained using a 25 μm inner diameter capillary at 17 °C with an effective length of 52 cm and a total
length of 62 cm. The electric field was 387 V/cm in reversed polarity. Sample was injected at 10 kV for 4
s. Reproduced with permission from: Lu, G.; Holland, L. A., Profiling the N-Glycan Composition of IgG with
Lectins and Capillary Nanogel Electrophoresis. Analytical Chemistry 2019, 91 (2), 1375-1383.
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1.2.2.4 Glycan derivatization for Capillary
Derivatization of N-glycans is critical for CE analyses to facilitate detection. This labeling
process also imparts charge on the neutral N-glycans rendering CE separation possible.
CE is a charged based separation, but in N-glycans only the sialylated glycans are
charged, with others being neutral. When separations are done in the neutral capillaries,
uncharged glycans will have a net mobility of zero, and will not be detected. In an
uncoated capillary the uncharged N-glycans will not resolve as the mobility will be the
same. Employing charged tags by derivatizing the glycans imparts a negative charge on
them, allowing the separation to happen based on the size of the glycan. The choice of
the tag added on the N-glycan is based on the method of detection targeted. Laserinduced fluorescence (LIF) and UV-Vis detection has been utilized to detect and identify
N-glycans by using fluorophores or chromophores, respectively.21,

22

Common

derivatization is done on the reducing end of the N-glycan, and labeling is 1:1, i.e. one
tag is added on each N-glycan. Traditionally, this derivatization is done through reductive
amination21-23 as shown by the reaction in Figure 1.8.
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Figure 1.8 Schematic of the reaction for the reductive amination labeling of
asparagine-linked glycans.

UV-Vis Derivatization of N-glycans
In UV-Vis absorbance detection, N-glycans are traditionally labeled with 2-aminobenzoic
acid (2AB) also called anthranilic acid,22 at the reducing end of the structure using
reductive amination. This labeling method imparts a negative 1 charge on the N-glycans,
which allows for the migration of neutral N-glycans under the influence of an electric field.
Commercially available filters are used to monitor the absorption of 2AB either at 214 or
254 nm. Several alternatives to 2AB have been reported in literature. 22, 24, 25 2AB is MS
compatible and has been shown to improve sensitivity and has cleaner spectra due to
lower interferences, as compared to other UV-Vis tags. 24
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There are several practical considerations for the 2AB labeling strategy. Figure 1.9
summarizes some of these considerations to be noted when carrying out a 2AB reaction.
Even though 8-aminopyrene-1,3,6-trisulfonic acid (APTS) labeling reaction are normally
carried out in tetrahydrofuran, this solvent significantly decreases labeling efficiency for
2AB labeling.26

2AB reactions are therefore normally carried out in methanol.

A

temperature of 65 °C achieves optimum labeling reaction in less than 2 hrs, with no benefit
realized by longer reaction times. When choosing the reaction pH, it has been reported

Figure 1.9 Effects of 2-aminobenzoic acid reaction conditions on the peak area.
A shows the impact of reaction solvent and B shows the impact of pH. C and D
shows the impact of temperature, with reactions in c carried out at 65C and
reactions in d carried out at 40C. Adapted with permission from: Sato, K.; Sato, K.;
Okubo, A.; Yamazaki, S., Optimization of Derivatization with 2-Aminobenzoic Acid
for Determination of Monosaccharide Composition by Capillary Electrophoresis.
Analytical Biochemistry 1998, 262 (2), 195-197.
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that very acid or basic pH reduces the reaction efficiency.26 A ratio of 7 2AB : 1 N-glycan
has been demonstrated to achieve 100% labeling at these conditions.19, 25, 26

Fluorescent derivatization of N-glycans
To enable fluorescence detection, free N-glycans are traditionally labeled with 8aminopyrene-1,4,6-trisulfonic acid (APTS),22, 23 at the reducing end of the structure using
reductive amination, although alternatives to this dye are commercially available. 27 This
labeling strategy imparts negative three charges on the N-glycan and facilitate migration
in an electric field. The excitation maximum of APTS dye matches the output of an argon
ion laser. Several labels have been developed to enable fluorescence detection in CE
and mass characterization in MS for CE-MS analysis.

There are several practical considerations to be noted when carrying out the APTS
reactions. Incubations are commonly carried out at 37 °C or 65 °C11, 19, 28, 29 depending
on the type of N-glycan to be labeled. The higher temperature is more desirable as
reaction reaches maximum in less than 2 hrs.28 This conditions is normally used for
desialylated glycans, as when sialylated N-glycans are labeled at this temperature there
is loss of sialic acids.28 Sialylated N-glycans are normally incubated at 37 °C. Acetic acid
at a composition of 20 % is normally included in the reaction as it has been shown to
improve labeling efficiency.28 When higher ratios of APTS to N-glycan are utilized,
labeling efficiency is improved, but more cleanup to remove excess dye are required after
the reaction.28
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Though APTS labeling strategies for CE-LIF are well established, improvements upon the
reaction continue to be reported.30-32 A new strategy addresses the practice of carrying
out the reactions in volumes of ≤ 5 mL in closed PCR vials.30

While increasing

concentration of acetic acid leads to more glycan labeling, lower reaction volumes
consistently result in more efficient N-glycan labeling.

A report demonstrated that

reactions subject to evaporation during labeling had higher product yield. 30 Reactions
incubated at 50 °C in a 3 mL volume versus a 13 mL volume supplemented with
tetrahydrofuran had a 2-fold increase in total area, which was attributed to improved
mixing. Reactions incubated at 50°C in a 3 mL volume performed in a closed versus an
open vial which had fully evaporated revealed a 4.5-fold improvement in labeling
efficiency, with < 5% relative standard deviation in N-glycan peaks measured using CELIF.

1.2.3 Sialic acid detection and quantification
N-glycans sialylation is related to several diseases, with the α2-3 vs α2-6 sialic acid
linkage identified as biomarker for diseases diagnosis and prognosis.

33, 34

However,

linkage analysis of sialic acids presents several challenges. Increases in α2-6 have been
reported in cancer.6, 34 The acute phase protein α-1-acid glycoprotein (AGP) sialic acids
have been shown as potential biomarkers for various cancers.33,

34

Complexity in

analyzing the distribution of α2-3 vs α2-6 sialic acid is compounded by the heterogenous
branching in most samples. Sialic acids are labile and can be lost due to handling or
storage. These factors present a challenge in differentiating α2-3 vs α2-6 sialic sialylation.
Clinically, sialic acid is quantified by isoelectric focusing, which separates the protein into
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bands depending on number of sialic acids present. 35 This current technique cannot
differentiate α2-3 vs α2-6 sialic sialylation.

1.2.3.1 High Performance Liquid Chromatography
High Performance Liquid Chromatography (HPLC) has been employed for the N-glycan
separation. The most common mode of HPLC employed for N-glycan fractionation and
enrichment is hydrophilic interaction chromatography (HILIC).36 Advances in HILIC has
enabled the method to be used to separate α2-3 vs α2-6 linked sialic acids.36-38 In order
to differentiate the isomers this chromatographic technique is sometimes hyphenated with
MS.36, 38-40 There is need to ensure that the salts from HILIC buffers do not interfere with
MS analysis. An alternative approach employs specific exoglycosidases enzymes offline
before analysis with HILIC.38 This chromatographic requires large buffer volumes, is labor
insensitive and may be time consuming.41

1.2.3.2 Mass spectrometry
Mass spectrometry is routinely used for N-glycan analysis but requires derivatization to
identify sialic acid linkages. The m/z of α2-3 vs α2-6 linked sialylated analytes the same,
which makes structural assignment ambiguous. Several strategies have been developed
to distinguish these isomers in MS.

The most common strategy utilizes chemical

derivatization like ethyl esterification,42 methylamidation or sialic acid linkage specific
alkylamidation.43

In some of these derivatization techniques these is

formation of

byproducts.44 and they convert the α 2-3 linked sialic acid to a lactone, which is prone to
hydrolysis.44 A different strategy has been to employ tandem MS45 but this may not be
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readily available. In separate studies, the exoglycosidases are initially used to remove
α2-3 linked sialic acids before analysis in MS.43, 46, 47

1.2.3.3 Capillary electrophoresis
The high separation efficiency and peak capacity of capillary electrophoresis make it
suited for separation of sialylated

N-glycans.16

Separations have been done to

differentiate α2-3 vs α2-6 sialic acids, in reverse polarity under suppressed EOF19 The
α2-6 sialic acids are arranged in a more compact structure with the N-glycan, forming a
more compact structure with the N-glycan as compared to the α2-3 linked sialic acids.48
This leads to subtle differences in size of the N-glycan when there is α2-3 linked sialic
acids vs α2-6 linked sialic acids. This yields a difference in the charge to size ratio of the
two molecules and this variation has been employed in capillary nanogel electrophoresis,
with the help of a single exoglycosidase, to distinguish α2-3 linked sialic acids vs α2-6
linked sialic acids in a sample with homogenous branching.19 The migration time of the
products is predictable as loss is sialic acid leads to a change in both charge and size,
which is observed as a shift to the right. For complex N-glycans containing α2–3 and α2–
6 sialylation, a different approach is required. A sample with mixed branching will yield
products with unpredictable migration time after the single enzyme treatment because the
products will have unpredictable charge to size ratio which makes interpretation difficult.
This confounds the interpretation of the electropherogram without the use of expensive
glycan standards.
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1.2.3.4 Other Approaches to distinguish sialic acids in complex samples with CE1
Several approaches have been taken to distinguish the sialic acids in CE.

In one

approach, the separation of sialic acid isomers was achieved following derivatization of
the sialic acid moieties and analysis using microfluidic CE laser-induced fluorescence.43
As shown in Figure 1.10, a total of 17 different glycans were separated and detected as
single peaks in less than 3 min. The carboxylic acids on sialic acids were neutralized by
converting them to methyl amines. Resolution was achieved due to subtle differences in
the hydrodynamic radius of different glycans containing α2-3 vs α2-6 linked sialic acids.
Microfluidic electrophoresis-laser-induced fluorescence enabled quantification of the
structures that contained each type of sialic acid linkage.

To correctly assign the

structures for microfluidic CE-laser-induced fluorescence, other complementary
techniques were used, including CE-MS, LC-MS, and MALDI-MS. Sialic acid linkagespecific alkylamidation, termed SALSA in many literature reports, was used to identify
linkage according to the mass shift of α2-6 linked sialic acids (+41.063 Da) as compared
to α2-3-linked sialic acids (+13.032 Da).

Further, structural assignments were

independently confirmed by cleaving the N-glycan mixture with a linkage specific enzyme,
α2-3 sialidase, and analyzing the cleaved N-glycan products.

1

Adapted with permission from Kristoff, C. J.; Bwanali, L.; Veltri, L. M.; Gautam, G. P.; Rutto, P. K.; Newton, E.
O.; Holland, L. A., Challenging Bioanalyses with Capillary Electrophoresis. Anal Chem 2020, 92 (1), 49-66. Copyright
© 2019 American Chemical Society

22

Figure 1.10 Electropherogram showing the separation of α2-3 and α2-6 linked sialic
acids in asparagine-linked glycans.
The sample was from human urinary exosomes. The trace is obtained using
microfluidic electrophoresis. Reproduced with permission from Song, W.; Zhou, X.;
Benktander, J. D.; Gaunitz, S.; Zou, G.; Wang, Z.; Novotny, M. V.; Jacobson, S. C. InDepth Compositional and Structural Characterization of N-Glycans Derived from
Human Urinary Exosomes. Analytical Chemistry 2019, 91, 13528 . Copyright 2019
American Chemical Society.
An alternative strategy to distinguish sialic acid linkage using derivatization chemistry and
CE-MS was also reported.44 For this research, free N-glycans were end-labeled using a
cationic moiety to facilitate electrophoretic separation and improve electrospray ionization
(ESI) in positive mode. The results are shown in Figure 1.11 where the extracted ion
electropherograms are displayed according to abundance. The upper trace is of peaks
at high abundance (>2%). The middle trace is of N-glycans at intermediate abundance
(from 0.5% to 1%).

The lower trace is of N-glycans at low abundance (<0.25%).

Differentiation of the α2-3 vs α2-6 linked sialic acid isomers was achieved through a two23

step derivatization process that resulted in ethyl esterification of α2-6 linked sialic acid
(+319 Da) and amidation of α2-3 sialic acids (+290 Da).

The CE-MS separation

conditions were modified to be compatible with the MS analyses with a commercial CE
instrument. Although these N-glycans were not fully resolved by the CE, the N-glycans
within peaks were distinguished by the MS. In addition, structures of even low abundant
peaks were identified. The separations obtained with the commercial instrument were
longer than those reported with the microfluidic device; however, the CE-MS method did
not need complementary techniques for structural identification.

Figure 1.11 Electropherogram of
asparagine-linked glycans with
α2-3 and α2-6 linked sialic acids
from human plasma.
The traces are obtained using
CE-MS. The upper trace (A) is
of N-glycans at high abundance
(>2%). The middle trace (B) is
of intermediate abundance (from
0.5% to 1%). The lower trace
(C) is of N-glycans at low
abundance (<0.25%). Adapted
from Macmillan Publishers Ltd.:
Nature Communications,
Lageveen-Kammeijer, G. S. M.;
de Haan, N.; Mohaupt, P.; Wagt,
S.; Filius, M.; Nouta, J.; Falck,
D.; Wuhrer, M. Highly sensitive
CE-ESI-MS analysis of Nglycans from complex biological
samples. Nature
Communications 2019, 10 (1),
2137 . Copyright
2019. https://www.nature.com/ar
ticles/s41467-019-09910-7.
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Approaches to leverage both the separation efficiency of CE and structural identification
of MS have also been described. CE separations of N-glycans were further analyzed
using drift tube ion mobility-MS.46 This approach identified isomeric α2-3 vs α2-6 sialic
acid linkages due to differences in drift time. CE-MS analysis of the distribution of all Nglycan features was reported for different therapeutic antibodies. 49

This middle-up

approach involving cleavage at the antibody hinge region identified 32 charge variants in
the Fc region, including sialylation. In a further effort to expand the use of CE-MS for
structural analyses of glycoprotein therapeutics, a validated method was reported to
characterize and quantify glycosylation 1 of 10 monoclonal antibodies.50 Glycopeptides
from each antibody were analyzed with both CE-ESI-MS and HILIC separations,
producing similar results as established through a comparison of the abundance of
different N-glycan structures.

Quantification of N-glycans in mass spectrometry can be impacted by differences in
ionization efficiencies. Instrumental modifications have been reported to address this by
simultaneously using laser-induced fluorescence detection with CE-ESI-MS.

Laser-

induced fluorescence was used to quantify glycans within the ESI Taylor cone obtained
with a commercially sourced porous sheathless tip.51 Peak areas of N-glycans had intraand inter-day reproducibility of 4% and 7%, respectively, when measured with laserinduced fluorescence. In order to compare the laser-induced fluorescence response to
the mass spectrometry signal, the percent area obtained for each N-glycan peak relative
to the total N-glycan area was determined using both detectors. The percent area
distribution obtained with MS revealed a significant decrease in signal for slower migrating
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peaks in comparison to the peak areas obtained with laser-induced fluorescence. An
alternative approach to N-glycan quantification with laser-induced fluorescence prior to
mass analysis adapted the cartridge of a commercial capillary instrument27 to interface
the capillary with a commercial microvial ESI source.52 The capillary was configured
outside of the commercial CE instrument by extending the length to 45 cm, making it
possible to insert the capillary outlet into the ion source using sheath flow.52

1.2.3 Biological reagents for asparagine-linked glycan analysis in capillary
electrophoresis
1.2.3.1 Exoglycosidase for glycan characterization
Exoglycosidase enzymes have been employed in capillary electrophoresis to identify
specific N-glycans linkages and quantify them.19, 53 This class of enzyme, hydrolyzes the
glycosidic linkage of N-glycans from the non-reducing end. Enzymes are monomer and
linkage specific and will only hydrolyze the glycosidic linkage if the enzyme specify
matches the terminal monomer on the N-glycan. Figure 1.12 summarizes the enzymes
commercially available and the monomers they target.

Analysis employing these

enzymes can performed either offline or online. Offline reactions involve enzymatic
digestion done in vial and when reaction is complete, the analytes are injected into the
capillary for analysis. Online reactions involve introducing the enzyme in the capillary,
injecting the sample to carry out enzymatic conversion, followed by separation.
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Figure 1.12 Illustration of exoglycosidase enzymes and the
glycosidic bond they cleave.
Offline reactions for glycan identification and quantification have been reported 46, 54, 55
Reactions are typically done overnight in a separate vial, and are quenched and purified
before injection and analysis in CE. This approach is time consuming, is more hands-on
and consumes higher volumes of enzyme. Online enzyme digestion of N-glycans has
also been reported.19, 29,

53

This approach integrates the enzymatic reaction and the

separation, without the need for quenching or purification. The ability of nanogels to
precisely pattern and control the enzyme was demonstrated. 19 The nanogels have
previously been used to pattern enzyme and lectins zones in capillary electrophoresis for
the analysis of N-glycans.

19, 53, 56

The use of phospholipid enabled the creating of

stationary enzyme zones and was shown to improve enzyme stability.19,

53

Low

nanomolar volumes of enzyme were consumed per each analysis and the study were
automated.19, 29 These analysis showed the attractiveness of incorporating the enzyme
reaction with separation in CE.
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Identifying the N-glycan is based on migration time shifts after the enzyme reaction.
When the N-glycan passes through the enzyme zone and the enzyme specificity matches
the terminal monomer, this monomer will be cleaved. This leads to a migration time shift
which can be compared to an electropherogram achieved without the enzyme, enabling
identification of the monomer cleaved. In the analysis of neutral N-glycans, only a loss in
size is observed which leads to an increase in the charge to size ratio. This is observed
in the electropherogram as peaks shifting to the left. In analysis of sialylated N-glycans,
the loss in sialic acids leads to a change in both the size and charge, resulting in a shift
to the left. This approach has been successfully used in capillary for single sialylated Nglycans19 and the purpose of the research in Chapter 3 was to extend it to more complex
mixtures.

1.2.3.2 Transferase Enzymes for N-glycan Modification
Glycosyltransferases enzymes are enzymes responsible for the transfer of sugar
monomers from one compound to another. Unlike exoglycosidase enzymes which cleave
glycosidic bonds, the glycosyltransferases are responsible for forming the glycosidic
bonds.

This enzyme class cleaves a monomer from a donor, usually nucleoside

mono/diphosphate,57 and adds it to an acceptor molecule. Figure 1.13 illustrates the
reaction of a glycosyltransferase.

Table 1.1 list some glycosyltransferase and the

glycosidic bond they generate. Wild type transferase enzymes are mainly concentrated
in the Golgi complex where they are responsible for N-glycan synthesis.57, 58 In biological
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therapeutics, glycosyltransferases

have been employed to tailor glycosylation of

therapeutic antibodies4, 59 thereby modulating activity.4

Figure 1.13 Illustration of a glycosyltransferase reaction where monomer is
transferred from donor to acceptor.

Table 1.1 Some glycosyltransferases and the monomers they add.
Glycosyltransferase

Monomer added

α2-3 Sialyltransferase

α2-3 Sialic acid

α2-6 Sialyltransferase

α2-6 Sialic acid

β1-4 Galactosyltransferase

Galβ1-4

Fucosyltransferase

α1-6 fucose
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Even though therapeutic IgG N-glycans play an important role in immune response,60-62
control of glycosylation poses challenge,60 and efforts have used mutant and wild type
transferase4,

62

to tailor the regio- and stereochemistry.60

IgG glycosylation during

synthesis is non template.

In order to control this glycosylation several strategies

including

chemoenzymatic

chemical

and

processing

have

been

utilized. 60

Chemoenzymatic synthesis is desired because it has been demonstrated to be
economically

efficient

and

generates

specific

glycosylation60,

63

Over

65

glycosyltransferases have been identified and characterized for chemoenzymatic
synthesis60 and new ones are in development.64 Challenges still exist in understanding
glycosyltransferase reaction mechanism, including kinetics and inhibition.60

Several assays are available for glycosyltransferase assays and they generally really on
monitoring radiolabeled sugar nucleotides or chromophore tagged neuclotides. 65 In a
radiolabeling assay, the transferred monomer is radiolabeled allowing for the monitoring
of the product. These assays are routinely utilized as they are sensitive and can be used
with low enzyme volumes.65 A drawback of these assays includes the need to quench
the reaction and remove the unreacted donor. Special licenses may be required for the
handling of radioactive materials.

Spectrophotometry assays have been reported,66, 67 with some commercially available
kits. They rely on the product being detectable in the presence of optically inactive
reactants. These methods are limited by their requirement of high enzyme volumes,65 as
µL or mL reaction volumes are utilized.66,
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67

High throughput assays utilizing

immunoassays have been developed.68 The acceptor is immobilized and the enzyme
and donor are then added for the reaction to occur. Kinetics studies are difficult since
limited acceptor is immobilized.68 In most available methods reactions are offline, large
enzyme volumes are consumed and multiple analysis have to be done. New strategies
should utilize low enzyme and substrate amounts, be fast and easily automated.

1.2.3.3 Lectin in glycans characterization
Lectins are glycan binding proteins that recognize specific sugars moieties. These sugar
binding proteins are used to identify the presence of a particular glycosylation. Table 1.1
illustrates some lectins utilized in glycan analysis, and the sugars that they bind. The
specificity of lectins has led to their employment in a variety of assays. High throughput
lectin arrays are commercially available and have been used in the analysis of
glycoproteins. Lectins have also been employed in affinity chromatography to fractionate
and enrich glycan samples. A competing sugar is used to elute the bound fractions after
capture.
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Table 1.2 Some lectins used in N-glycan analysis.
Lectin

Primary Specific Sugar

Maackia Amurensis Lectin (SNA)

α2-3 Sialic acid

Sambucus Nigra Agglutinin (SNA)

α2-6 Sialic acid

Erythrina Cristagalli Lectin (ECL)

Terminal Galβ1-4

Aleuria Aurantia Lectin (AAL)

α 1-6 fucose

Ulex Europaeus Agglutinin (UAE)

α fucose

Lectins have been employed in capillary electrophoresis to identify N-glycans.11, 53, 56 The
lectins are either patterned as stationary zones11, 53, 56 or the whole capillary is filled with
the lectin.69 It is more desirable to have stationary zones of lectins as enzymes can also
be integrated as separate zones to enrich the information gained. 53

Phospholipid

nanogels are compatible with lectins and allow for the patterning of these discrete
zones.11, 53 Once an analysis is done the lectin zone is expelled and a different lectin
patterned. This approach was employed in a previous study to identify bisected Nglycans, sialylated, fucosylated and galactosylated N-glycans from IgG.11 Identification
of the N-glycans with lectins was based on disappearance of peak from electropherogram
when lectin is present compared to an electropherogram without lectin.
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1.3 Conclusions
The chapter outlined the background information which is important for the studies done
in Chapter 2 and 3 and for the future directions outlined in Chapter 4. Fundamentals of
capillary electrophoresis separations were discussed.

Relevant information on

phospholipid nanogels and how they have been employed in the analysis of N-glycans
was also provided. Material on strategies for labeling N-glycans for optical detection in
CE was then provided. Furthermore, the Chapter outlined the current status of analysis
of sialic acids, with a comparison done between CE and other cutting-edge techniques.
Important information about use of enzymes and lectins was outlined. This information
is pertinent to the research done in Chapter 2 and 3.
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Chapter 2 : Quantification of the α2-6 Sialic Acid Linkage in
Branched Asparagine-Linked Glycan Structures with
Capillary Nanogel Electrophoresis

Reproduced with permission from: Bwanali, L.; Newton, E.; Crihfield, C. L.; Zeger, V.;
Gattu, S.; Holland, L. A., Quantification of the α2-6 sialic acid linkage in branched Nglycan structures with capillary nanogel electrophoresis. Analytical Chemistry. 2020, 92
(1), 1518-1524. Copyright © 2019 American Chemical Society
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2.1 Introduction
Asparagine-linked carbohydrates, or N-glycans, are a type of post-translational protein
modification that impacts physiological function. N-linked glycans have a common core
structure1 which can be modified such that the non-reducing terminus is capped with sialic
acid that is α2-3 or α2-6 linked to galactose residues. Sialic acid linkage is a direct
measure of altered synthesis, metabolism, and regulation because the processes that
affect sialic acid linkage are controlled by glycosyltransferases, glycosidases, and a
variety of feedback mechanisms.2-4 Increases in the amount of α2-6 linked sialic acids in
serum proteins is reported in cancer.3, 5 For example, the sialic acid linkages of alpha-1acid glycoprotein (AGP) in serum are associated with liver, pancreatic, and kidney
cancer.6, 7

Analyses of N-glycan isomers with different sialic acid linkages are challenging.
Sialylation can be heterogeneous and sialic acid residues are labile.

Currently the

measurement of sialic acid linkage is achieved utilizing chemical derivatization 8-10 or
tandem MS.11 Moreover, the linkage specific enzyme α2-3 sialidase is used to further
verify the linkage composition.8,

12

Because the distribution of N-glycan structures is

complex, glycan samples must be fractionated prior to analyses. Promising strategies for
fractionating complex N-glycan samples include HILIC,13, 14 ion mobility spectrometry,12,
15

and microfluidic or capillary electrophoresis. 8, 10, 12

Capillary electrophoresis has high separation efficiency and high peak capacity, making
it ideally suited for complex N-glycan samples.16
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Because capillary electrophoresis

separations are based on differences in charge-to-size ratio, they are affected by the
highly charged nature of sialylated N-glycans. Thus, sialic acids are best resolved using
reverse polarity and suppressed electroosmotic flow. Under these conditions, the anionic
glycans are driven to the detector via electrophoretic transport. If a high viscosity media
is also included in the background electrolyte, additional separation enhancement is
observed as subtle differences in shape (i.e. sialic acid linkage isomers) are intensified
by an increase in the frictional drag.

Capillary nanogel electrophoresis has been used to simultaneously separate and identify
glycan structures.17-19 In this approach a stationary zone of exoglycosidase enzyme was
included near the injection end of the separation capillary. The enzyme in the capillary
cleaved specific terminal N-glycan monomers. For neutral residues such as galactose or
N-acetylglucosamine, this resulted in a change in the size of the glycans, but not the
charge, when monomers were cleaved. This created a migration time shift of product
from that of the substrate allowing identification and quantification. This approach was
effective for analyzing mixtures of asialylated N-glycans,18-20 or a single sialylated Nglycan for sialic acid linkage.18 Sequencing complex mixtures containing sialic acids with
capillary electrophoresis and exoglycosidases is more difficult because removing the
sialic acid changes both charge and size. For complex N-glycans containing both α2-3
vs α2-6 linked sialylation, the products do not have predictable charge-to-size ratio
confounding interpretation of the electropherogram without the use of expensive glycan
standards.
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Figure 2.1 Conceptual diagram of quantification of α2-6
sialic acids in a sample with both α2-3 and α2-6 sialic acids.
The α2-3 are removed by α2-3 sialidase, followed by removal
of exposed galactose by β1-3,4 galactosidase. The enzyme
α2-3,6,8 sialidase is the used to cleave α2-6 sialic acids.
Galactose residues remaining are those which were initially
under α2-6 sialic acids.

With this multiple enzyme

sequencing the α2–6-linked sialic acid residues on the Nglycan correlates directly to the number of terminal galactose
residues that remains. Reproduced with permission from:
Bwanali, L.; Newton, E.; Crihfield, C. L.; Zeger, V.; Gattu,
S.; Holland, L. A., Quantification of the α2-6 sialic acid linkage
in branched N-glycan structures with capillary nanogel
electrophoresis. Analytical Chemistry. 2020, 92 (1), 15181524. Copyright © 2019 American Chemical Society.
In this study, enzymes were patterned in an order that simplified the mass shift
interpretation, enabling the analysis of complex mixtures of α2-3 and α2-6 linked
sialylation (Figure 1.1). The approach was used for the analysis of N-glycans with
different branching, and consumed only nanoliter volumes of enzyme, sample, and
phospholipid.

The N-glycans injected into the capillary were passed through three

enzyme zones.

The first enzyme zone contained α2-3 sialidase, which specifically
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cleaved α2-3 linked sialic acids (Figure 1.1). The modified N-glycan then migrated
through the second zone that contained β1-3,4 galactosidase, which cleaved terminal
galactose. Employing α2-3,6,8 sialidase then removed the α2-6 linked sialic acids. With
this process of in-capillary enzyme modification and separation, shifts in migration time
reflected the α2-6 linked sialic acid composition and the amount of α2-6 linked sialic acid
correlated directly to the number of galactose residues on the N-glycan (Figure 1.1). This
enzyme-based approach provided quantitative information about the amount of α2-6
linked sialic acid for biantennary, triantennary, and tetraantennary N-glycans.

The

multiple enzyme approach was validated with a sialylated N-glycan standard and used
together with lectins to quantify α2-6 linked sialic acid in AGP which is a heavily sialylated
positive acute phase protein which serves as a marker of disease.

2.2 Materials and methods
2.2.1 Chemicals and reagents
The sialylated triantennary complex N-glycan (GKC-335300), Human AGP N-Linked
Glycan Library (GKLB-001), α2-3 sialidase (GK80021 Sialidase S,) and the β1-3,4
galactosidase (GKX-5013) were from Agilent (Santa Clara, CA, formerly Prozyme
Hayward, CA).

Acetic acid was from Fisher Scientific (Pittsburgh, PA).

Sodium

phosphate, 8-aminopyrene-1,3,6-trisulfonic acid, triethylamine, AGP, acetonitrile, sodium
hydroxide, methanol, sodium acetate, α2-3,6,8 sialidase (N2876-6UN) and sodium
cyanoborohydride (dissolved in tetrahydrofuran) were from Sigma-Aldrich (St. Louis,
MO).

Aleuria aurantia lectin (AAL), Erythrina Cristagalli lectin (ECL), and Maackia

Amurensis lectin (MAL) were from Vector Labs (Burlingame, CA).
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PNGase F was

purchased from New England Biolabs (Ipswich, MA). Deionized water was from an Elga
Purelab ultra water system (Lowell, MA). The phospholipids 1,2-dimyristoyl-sn-glycero3-phosphocholine (DMPC) and 1,2-dihexanoyl-sn-glycero-3-phosphocholine (DHPC),
were from Avanti Polar Lipids (Alabaster, AL). Nanogels were prepared by weighing
phospholipids and combining them such that [DMPC]/[DHPC] = 2.5. The phospholipids
were dissolved in an aqueous solution of 50 mM sodium acetate buffered to pH of 5.0 to
achieve a concentration of 10, 20, or 40% weight/volume. The process to reconstitute
phospholipids has been described previously.19-21 Each preparation was then aliquoted
and stored at −20 °C

2.2.2 Preparation and derivatization of standards.
The glycans were labeled with a fluorescent chromophore as previously described.
22

The sample 1 glycans were cleaved from AGP as described previously.

20

19, 20,

Glycan

samples were purified using DPA-6s columns and stored at -20 °C as described
previously.22 For further analysis glycan samples were diluted at least 50-fold in 1 mM
sodium acetate buffered to pH 5.

2.2.3 Preparation of enzymes.
All enzymes were reconstituted so that the appropriate concentration of enzyme was in
20% phospholipid buffered at pH 5 with 50 mM sodium acetate. The separation and
enzyme zones were buffered at pH 5, which was compatible with enzyme conversion 2325

and was near the isoelectric point of the enzymes. At this pH the enzymes will be

essentially stationary in the capillary in the absence of electroosmotic flow. The α2-3,6,8
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sialidase powder was reconstituted to a concentration of 250 mUnits/µL with 50 mM
sodium acetate buffered to pH 5. The appropriate volume of master stock (1 µL) was
diluted with 20% nanogel to a final enzyme concentration of 5 mUnits/µL. For the α2-3
sialidase, 1 µL of enzyme was reconstituted in 20% nanogel in sodium acetate
phospholipid buffered at pH 5 to a concentration of 2 mUnits/µL. The appropriate volume
of master stock was diluted with 20% nanogel to make concentrations between 5
µUnits/µL and 750 µUnits/µL. For analysis using β1-3,4 galactosidase, this enzyme was
desalted and concentrated to 20 mUnits/µL using a 10 kDa molecular weight cut-off filter
(UFC01025 EMD Millipore, Burlington, MA). The 20 mUnits/µL preparation was mixed
with 40% nanogel to achieve a solution with final concentrations of 10 mUnits/µL β1-3,4
galactosidase in 20% nanogel buffered to pH 5 with sodium acetate.

2.2.4 Preparation of lectins.
Lectins (i.e. AAL, ECL, MAL) were desalted prior to use. The salts were removed using
a 10 kDa molecular weight cut-off filter. The lectins were rinsed with a solution 50 mM
sodium phosphate buffered to pH 6, and each lectin was then collected from the molecular
weight cut-off filter.

Each lectin sample was then mixed 1:1 with a 40% nanogel

preparation that contained 50 mM sodium acetate buffered to pH 5. The final pH was
approximately 5.5. The final concentration of the lectin preparation was 250 μM AAL, 150
μM ECL, or 100 μM MAL in 20% nanogel.
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2.2.5 Capillary electrophoresis.
Analyses were performed using a SCIEX MDQ Plus (Sciex, Redwood City, CA)
configured by the manufacturer with laser induced fluorescence detection and appropriate
filters (3 mW solid state laser with λex = 488 nm, λem = 520 nm). Silica capillaries with a
25 μm internal diameter and 360 μm outer diameter fused silica capillary (Polymicro
Technologies, Phoenix, AZ) were used for the separations. Each day capillaries were
prepared as previously described. The electrophoresis was performed using reversed
polarity to separate the negatively-charged APTS-labeled glycans (anodic reservoir near
detector, cathodic reservoir near the site of injection). The background electrolyte was
50 mM sodium acetate buffered to a pH of 5. Prior to each run the capillary was held at
15 °C and the 40% nanogel was introduced in the capillary. Ambient thermal control of
the room and instrument was maintained using a portable air conditioner as was
described previously.26 This temperature was maintained between 14 to 16 °C. Large
deviations in the ambient temperature resulted in irreproducible nanogel introduction and
plug patterning.

For enzyme patterning, the zones were introduced in the opposite order they are in
contact with the glycan (see Figure 2.2). Patterning in the capillary was an automated
process performed by the capillary electrophoresis instrument in multiple steps.
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Figure 2.2 Illustration of in capillary reaction showing that presence of α2–6-linked sialic acid
is related to galactose residues following processing with serial enzymes
(A) Saccharides are represented with nomenclature defined by the Consortium for
Functional Glycomics. (B) Electropherogram showing migration time shifts based on the
number of terminal galactose residues present. (C) Verification of the α2–6-linked sialic acid
distribution following treatment with α2–3 sialidase only. Areas labeled in the traces are
normalized to the internal standard (IS). Y axis for trace C is normalized to the internal
standard in trace B. Runs were performed in triplicate. See Tables 2.1, 2.2, 2,3, and 2.4
for raw and normalized areas. Separations performed at 23 °C in a 25 μm i.d. capillary with
an effective length of 50 cm and E = 450 V/cm (reverse polarity). Preseparation at 4 kV for
9 min to drive substrate past enzyme plug. All enzymes are suspended in 20% nanogel with
50 mM sodium acetate buffered to pH 5. Reproduced with permission from: Bwanali, L.;
Newton, E.; Crihfield, C. L.; Zeger, V.; Gattu, S.; Holland, L. A., Quantification of the α2-6
sialic acid linkage in branched N-glycan structures with capillary nanogel electrophoresis.
Analytical Chemistry. 2020, 92 (1), 1518-1524. Copyright © 2019 American Chemical
Society.
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First, the capillary was filled with 40% nanogel. Second, the α2-3,6,8 sialidase enzyme
zone was introduced at 20.7 kPa (3 psi) for 14 s which was calculated to 1.6 mm. For the
calculation, a plug of APTS was pushed with 20% nanogel at 3 psi. It took the APTS 14.8
min to cover 10.2 cm (102 mm), therefore 8.75 s introduction of the nanogel plugs covers
1 mm. The α2-3,6,8 sialidase enzyme zone was followed by injection of background
electrolyte at 3.4 kPa (0.5 psi) for 5 s. The 3 psi 14 s α2-3,6,8 sialidase enzyme zone
was calculated to be 1.6 cm. The purpose of the 5 s introduction of background electrolyte
was to clean the outer surface of the capillary. A 10% lipid spacer at 20.7 kPa (3 psi) 20
s was then introduced to prevent contamination. Third, the β1-3,4 galactosidase was
introduced at 20.7 kPa (3 psi) for 42 s (calculated to be 4.8 mm) followed by injection of
background electrolyte at 3.4 kPa (0.5 psi) for 5 s, and then a 10% lipid spacer at 20.7
kPa (3 psi) 20 s. Fourth, the α2-3 sialidase was then introduced at 20.7 kPa (3 psi) for
14 s (1.6 mm) followed by injection of background electrolyte at 3.4 kPa (0.5 psi) for 5 s,
and then a 10% lipid spacer at 20.7 kPa (3 psi) 20 s. Finally, the AAL zone was patterned
into the capillary at 20.7 kPa (3 psi) for 28 s (2 mm) followed injection of 10% nanogel at
13.8 kPa (2 psi) for 23 s and then a background electrolyte pre-plug of 13.8 kPa (2 psi)
for 20 s. After the capillary was filled, the temperature of the separation was increased
to 23 °C for the sample injection, incubation, and separation. Sample injections were at
8 kV 5 s followed by a background electrolyte post-plug of 13.8 kPa (0.5 psi) for 5s. After
a run was complete, a 276 kPa (40 psi) background electrolyte flush for 15 min was
applied in the reverse direction to push out any remaining protein toward the site of
injection. Data collection and analyses were performed using 32 Karat Software version
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10.2. Reducing the velocity while passing through the enzyme zone maximized enzyme
conversion.17 Therefore, a pre-separation at 4 kV for 9 minutes in the beginning of the
run was performed to drive substrate through the enzyme zones.

2.2.6 Statistical analysis.
Significance testing was used to compare peak areas for optimization of residue cleavage
from N-glycans for different enzymatic methods. The samples were considered to be
normally distributed, assuming only random error existed in the measurement, and
independent. Levene’s test was used to remove bias from the statistical analysis when
choosing between a pooled t-test and a Welch test. In every case, at the 0.01 significance
level, the results of Levene’s Test did not support a significant difference in sample
(group) variance, indicating a 2-sided pooled t-test be conducted for all comparisons.

2.3 Results and discussion
2.3.1 Serial enzyme processing to determine α2-6 linked sialic acid.
The amount of α2-6 linked sialic acid was quantified by modifying the N-glycan so that
the number of α2-6 linked sialic acids was related to the number of galactose residues
remaining after sequential in-capillary digestion. As depicted in Figure 2.2, the separation
capillary was patterned so that the APTS labeled N-glycan passed through three
successive zones which were α2-3 sialidase, β1-3,4 galactosidase, and α2-3,6,8
sialidase. Migration through the first two zones resulted in cleavage of any α2-3 linked
sialic acid (zone 1) and the penultimate galactose (zone 2) attached to the cleaved α2-3
linked sialic acid (Figure 2.2A first arrow). Migration through the third zone cleaved the
α2-6 linked sialic acid (Figure 2.2A second arrow). As a result, the galactose residues
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remaining on the products were those that were linked to the α2-6 linked sialic acids. A
unique advantage of this method is that it can be applied to fully or partially sialylated Nglycans because the lack of a sialic acid does not impact the quantification of the α2-6
linked sialic acid residues. It was established in the literature 27 that α2-3 linked sialic
acids are more readily cleaved than α2-6 linked sialic acids because of structural
differences. As α2-3 linked sialic acid is more susceptible to loss associated with sample
handling, derivatization, or storage, quantification of α2-6 linked sialic acid is a viable
strategy for linkage analyses of physiological samples.

2.3.2 Quantifying α2-6 linked sialic acid in a triantennary asparagine-linked glycan
standard.
A sialylated N-glycan standard was enzymatically processed in-capillary to demonstrate
the feasibility of enzyme-based quantification of α2-6 linked sialic acid. The top trace of
Figure 2.2B shows the stepwise shift in migration that occurred with each additional loss
of a galactose residue. The structures were identified by migration order to determine the
number of α2-6 linked sialic acid residues, which was measured as area. The α2-6 linked
sialic acid distribution on the triantennary N-glycans summarized in Figure 2.2B was
similar to that reported by the vendor,28 which for the triantennary structures containing
0, 1, 2, and 3 α2-6 linked sialic acids was reported to be 4%, 51%, 36%, and 5%, with 3%
of the composition ambiguous. The normalized areas used to achieve this distribution are
shown in Table 2.1 and the raw areas in Table 2.2. As shown in Figure 2.2B, split peaks
were observed for the mono- (i.e. 23.1, 23.4 min) and disialylated (i.e. 24.7, 25.1 min)
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structures. This peak splitting was due to the asymmetry of the structure emanating from
the α1-3 and α1-6 mannose at the N-glycan core.29
Table 2.1 Normalized areas for Figure 2.2B employed for establishing
α2-6 linked sialic acid in triantennary standard using multiple
enzymes.

1
SEQUENCE
850
SEQUENCE
853
SEQUENCE
869

2

3

4

Total

NORM
33373 558459 323558 13807 929197
NORM
32223 530390 339330 15797 917739
NORM
39277 545098 326597 14430 925402

AVERAGE

34957 544649 329828 14678 924113

RSD
11
3
3
7
1
Areas normalized to internal standard (I.S.) within the data set. A
correction factor was achieved by dividing the I.S. area in each run
by highest I.S. within data set. The glycan area was then multiplied
by corresponding this correction factor.

Table 2.2 Raw areas for Figure 2.2B employed for establishing α2-6
linked sialic acid in triantennary standard using multiple enzymes.

I.S
SEQUENCE RAW
850
SEQUENCE RAW
853
SEQUENCE RAW
869
AVERAGE
RSD

1

2

3

4

Total

71184 33373 558459 323558 13807 929197
70783 32041 527402 337418 15708 912569
68085 37567 521367 312379 13802 885115
70017 34327 535743 324452 14439 908960
2
8
4
4
8
2
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2.3.3 Verification of serial enzyme processing
The fidelity of three zone enzyme processing was verified by analyzing the migration
order and areas obtained for the triantennary N-glycan standard using only the first zone
of α2-3 sialidase (Figure 2.2C). If the peak assignment is correct, then when enzyme
conversion is as expected the areas of peaks associated with structures of the same sialic
linkage composition will be the same. The order of migration of the peaks obtained with
a single α2-3 sialidase treatment was reversed when compared to the order obtained with
the 3 enzyme processing. This was due to the difference in mobility associated with the
sialic acid charge. Another notable difference was that the peaks obtained with the single
enzyme treatment were not symmetrically spaced because the sialic acid residue was
charged. The peak splitting of the mono-galactosylated and di-galactosylated structures
observed in trace B and in other reports22, 30 for asialylated peaks was not observed in
the partially sialylated glycans. This was attributed to the conformation of sialylated
residues forming structures with similar hydrodynamic radius. In fully sialylated glycans
the α2-6 linked sialic acids were reported to adopt a more compact structure with the
penultimate galactose residues.27

In another report fully sialylated N-glycans were

reported to adopt structures that allowed the sialic acid to fold against the Nacetylglucosamine residues at the reducing terminus of the structure.29 With the peak
identities associated with each structure assigned, the areas obtained with the 3 enzyme
versus the single enzyme treatment were compared.

No significant difference was

observed in the areas obtained between the single enzyme in Figure 2.2C (normalized
areas in Table 2.3 and raw area in Table 2.4) and the three-enzyme analysis in Figure
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2.2B (normalized areas in Table 2.1 and raw areas in Table 2.2) at a 0.01 significance
level, when compared using a two-sided pooled T test.
Table 2.3 Normalized areas for Figure 2.2C used to validate α2-6 linked sialic acid
in triantennary standard using α2-3 sialidase.

1

2

3

4

Total

α2-3 Sialidase enzyme Run #918

20742 294943 513660 43468 872813

α2-3 Sialidase enzyme Run #921

22333 315809 550077 47430 935649

α2-3 Sialidase enzyme Run #924

21045 311713 539305 46202 918266

AVERAGE

21373 307489 534348 45700 908909

RSD
4
4
4
4
4
Areas normalized to internal standard (I.S.) within the data set. A correction factor
was achieved by dividing the I.S. area in each run by highest I.S. within data set.
The glycan area was then multiplied by corresponding this correction factor.

Table 2.4 Raw areas for Figure 2.2C used to validate α2-6 linked sialic acid in
triantennary standard using α2-3 sialidase.

I.S.

1

2

3

4

Total

α2-3 Sialidase enzyme Run #918 69410 19327 274827 478627 40503 813284
α2-3 Sialidase enzyme Run #921 69684 20055 283600 493975 42593 840223
α2-3 Sialidase enzyme Run #924 67886 18899 279922 484302 41490 824613
AVERAGE
RSD

68993 19427 279450 485635 41529 826040
1

3
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2

2

3

2

2.3.4 Working range of specific sialidase.
Although α2-3 sialidase was specific for α2-3 linked sialic acid, at sufficiently high
concentration it will cleave α2-6 linked sialic acid at a slower velocity. The concentration
of 250 µUnits/µL α2-3 sialidase used for the analyses in Figure 2.2 was verified to ensure
that the amount of α2-3 sialidase was sufficient to fully convert α2-3 linked sialic acids,
but did not cleave α2-6 sialic acid. The same concentration of triantennary standard that
was used to quantify the α2-6 linked sialic acid in Figure 2.2B was used to evaluate the
working concentration range of the specific sialidase. A different instrument was used for
this study. Although the response of these instruments differs the ratio of the peak area
of the N-glycan to that of the internal standard is similar (Table 2.5).
Table 2.5 Comparison of triantennary glycan to internal standard
areas across instruments for each enzyme condition.
Ratio
I.S.
Glycan
glycan
area
area
area to IS Instrument
Triantennary
standard
Specific enzyme
range study
70000 909000
13
1
Multiple enzyme
sequencing study
28000 337000
12
2
Internal standard (I.S.) and glycan areas are averages of 3
replicates performed on each instrument. The total glycan area
was divided by total standard area.
In-capillary digestions were performed at α2-3 sialidase concentrations of 250 μUnits/µL
(Figure 2.3B) and 750 μUnits/µL (Figure 2.3A) and the distribution of desialylated peaks
compared. The peaks produced by these in-line enzyme reactions had reproducible
migration times and areas, with the relative standard deviation less than 1% and less than
10%, respectively. The areas of the product peaks obtained at these two concentrations
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(normalized areas Table 2.6 and raw areas Table 2.7) were not significantly different at a
0.01 significance level when compared using a two-sided pooled T test. When lectin with
high specificity to α2-3 sialic acids (MAL) was included in the capillary (Figure 2.3C), no
difference was observed in the trace, which further confirmed that the α2-3 sialic acids
were completely cleaved from the sample. A lower concentration of α2-3 sialidase (5
μUnits/µL) generated incomplete cleavage of α2-3 linked sialic acid (Figure 2.3D).

Figure 2.3 Concentration range of α2-3 sialidase for triantennary asparagine-linked glycan.
The concentration range of α2-3 sialidase enzyme suitable for complete conversion of α2-3
linked sialic acid, but not α2-6 linked sialic acid is established for triantennary standard.
Electropherograms obtained at 250 µUnits/µL (B) and 750 µUnits/µL (C) enzyme are not
significantly different. When MAL lectin specific for α2-3 linked sialic acid is included with 250
µUnits/µL enzyme (C) no change is observed confirming complete removal of α2-3 linked
sialic acid. At concentrations lower than this working range (D) partial conversion is achieved
(5 µUnits/µL). Separations condition are similar to Figure 2.2. Reproduced with permission
from: Bwanali, L.; Newton, E.; Crihfield, C. L.; Zeger, V.; Gattu, S.; Holland, L. A.,
Quantification of the α2-6 sialic acid linkage in branched N-glycan structures with capillary
nanogel electrophoresis. Analytical Chemistry. 2020, 92 (1), 1518-1524. Copyright © 2019
American Chemical Society.
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Table 2.6 Figure 2.3 normalized areas of α2-3 sialidase working concentration range for
triantennary standard.

1

2

3

4

Total

750 µUnits/µL α2-3 Sialidase enzyme Run #707

11408

143357 246066 20340

421171

750 µUnits/µL α2-3 Sialidase enzyme Run #710

10300

141073 241576 19763

412711

750 µUnits/µL α2-3 Sialidase enzyme Run #713

10067

139303 238550 19270

407190

AVERAGE

10592

141244 242064 19791

413691

RSD

7

1

2

3

2

250 µUnits/µL α2-3 Sialidase enzyme Run #671

9868

139788 227833 21253

398741

250 µUnits/µL α2-3 Sialidase enzyme Run #675

10874

135152 240907 23125

410059

250 µUnits/µL α2-3 Sialidase enzyme Run #720

10112

136564 223189 19518

389383

AVERAGE

10285

137168 230643 21299

399394

RSD

5

250 µUnits/µL α2-3 Sialidase + MAL Run #726

10719

5 µUnits/µL α2-3 Sialidase enzyme Run #638

28313

5 µUnits/µL α2-3 Sialidase enzyme Run #641

2

4

8

3

128733 224207 17721

381379

134837

141121

19471

—

323742

25619

132488

146714

21617

—

326438

5 µUnits/µL α2-3 Sialidase enzyme Run #644

26186

142744

140036

19135

—

328101

AVERAGE

26706

136690

142624

20074

326094

5

4

3

0

1

RSD

Areas normalized to internal standard (I.S.) within the data set. A correction factor was
achieved by dividing the I.S. area in each run by highest I.S. within data set. The glycan
area was then multiplied by corresponding this correction factor.
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Table 2.7 Figure 2.3 and Table 2.6 raw areas of α2-3 sialidase working concentration
range for triantennary standard.

750 µUnits/µL α2-3 Sialidase enzyme Run
#707
750 µUnits/µL α2-3 Sialidase enzyme Run
#710
750 µUnits/µL α2-3 Sialidase enzyme Run
#713
AVERAGE
RSD
250 µUnits/µL α2-3 Sialidase enzyme Run
#671
250 µUnits/µL α2-3 Sialidase enzyme Run
#675
250 µUnits/µL α2-3 Sialidase enzyme Run
#720
AVERAGE
RSD

IS

1

28521

9737

122361 210027 17361

359486

28715

8851

121230 207597 16983

354661

28768

8667

119930 205375 16590

350562

28668

9085

121174 207666 16978

354903

0

6

28444

8400

118992 193939 18091

339422

27840

9060

112603 200714 19267

341644

28270

8555

115537 188824 16513

329429

28185

8672

115711 194492 17957

336832

1

4

3

7279

87422

152258 12034

258993

250 µUnits/µL α2-3 Sialidase + MAL Run #726 22692

2

1

3

1

3

4

2

8

Total

1

2

5 µUnits/µL α2-3 Sialidase enzyme Run #638

33415 28313

134837

141121

19471

—

323742

5 µUnits/µL α2-3 Sialidase enzyme Run #641

33392 25601

132397

146613

21602

—

326213

5 µUnits/µL α2-3 Sialidase enzyme Run #644

32387 25380

138353

135728

18546

—

318007

AVERAGE

33065 26431

135196

141154

0

302781

2

4

0

1

RSD

2

6
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For this study it was unnecessary to establish a working range for the β1-3,4
galactosidase or the α2-3,6,8 sialidase because stepwise sequencing was only
dependent upon these enzymes being above a minimum threshold for complete
digestion.

Concentrations of 10 mUnits/µL and 5 mUnits/µL, were used for β1-3,4

galactosidase or the α2-3,6,8 sialidase, respectively.

These concentrations were

selected as working at higher concentrations increased the potential to foul the capillary
surface, which required more substantial flushes in-between the separations to maintain
reproducible peak migration times and areas. These experiments confirmed that the
enzyme processing strategy effectively quantified the abundance of sialic acid linkages
for a single N-glycan standard; however, in order to apply the approach to sialylated
glycoproteins it was evaluated with mixtures of N-glycans.

2.3.5 Measuring the α2-6 sialic acid content simultaneously in a mixture of
asparagine linked glycans.
To analyze glycan mixtures, sample migration windows and branching distribution were
established from reference traces shown in Figure 2.4A for AGP, which contains bi-, tri-,
and tetraantennary N-glycans. The N-glycans were cleaved from AGP and labeled with
APTS prior to in-capillary desialylation and separation. In-capillary enzyme processing
cleaved the N-glycans to the terminal N-acetyl glucosamine (Figure 2.4A blue trace) or
galactose residues (Figure 2.4A black trace). A lectin specific for fucose (AAL) was used
to remove fucose containing structures. This produced three peaks (Figure 2.4A) for
which the migration times delineated the range of the stepwise shift for each branched
structure. The area of each branched structure obtained from triplicate runs (Table 2.8
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Table 2.9 and Table 2.10) was used to assist in the analyses and were normalized to a
mannose trisaccharide internal standard. The peak overlap of the fully galactosylated
biantennary and the agalactosylated tetraantennary structures was addressed in α2-6
sialic acid determinations that followed by including a lectin with specificity to galactose
residues (ECL) in processing. This removed the biantennary structure which allowed for
quantification of the tetraantennary structure (Figure 2.4B blue trace).

Figure 2.4 Online serial enzyme sequencing of α-1-acid glycoprotein sample 1.
(A) reference traces establish the area associated with biantennary, triantennary, and
tetraantennary glycans. (B) the α2-6 linked sialic acid area of each branched structure
is established through serial enzyme processing in the absence of ECL (black trace).
Presence of ECL(blue trace) identifies agalactosylated glycans in co-migrating peaks.
Separation conditions are as specified in Figure 2.2. The asterisk denotes contaminant
peaks. Reproduced with permission from: Bwanali, L.; Newton, E.; Crihfield, C. L.;
Zeger, V.; Gattu, S.; Holland, L. A., Quantification of the α2-6 sialic acid linkage in
branched N-glycan structures with capillary nanogel electrophoresis. Analytical
Chemistry. 2020, 92 (1), 1518-1524. Copyright © 2019 American Chemical Society.
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Table 2.8 Peak area of α2-6 linked sialic from α-1-acid
glycoprotein glycans.
3

α2-6 linked sialic acid ( ) area x 10 (RSD)
Branch
0
1
2
3
4
Total
25(10) 89(7)
0
114(12)
⎯
⎯
⎯
104(5) 336(8)
0
0
440(9)
94(7) 265(3)
0
0
0
359(8)
Areas and relative standard deviation (RSD) of 2, 3, and 4
branch N-glycans from normalized alignment traces are: 107
(4), 433 (1), and 374 (2), respectively. Normalization is based
on the highest quantified area for the internal standard within
the alignment traces, sequencing traces, and sequencing
traces with ECL (i.e. 35,090 RFU). Solid lines in the table
indicate that the structure not possible. Separation conditions
are as stated Figure 2.1.
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Table 2.9 Figure 2.4 normalized peak areas for α2-6 sialic acid structural
assignments using multiple enzyme in α-1-acid glycoprotein sample 1.

1

2

3

4

5

27247

201870

129442

310752

274218

22347

181777

132156

291294

261339

24964

194471

128371

297874

260301

AVERAGE

24853

192706

129990

299973

265286

STDEV

2452

10162

1951

9897

7753

10

5

2

3

3

SEQUENCE -ECL Run
#584
SEQUENCE -ECL Run
#587
SEQUENCE -ECL Run
#590

RSD

1

2ECL

4ECL

24306

108384

100027

107138 439370 383185 607

23956

97361

86918

103307 428784 372994 610

27048

105262

95561

111445 429644 364836 538

AVERAGE

25103

103669

94169

107297 432599 373672

STDEV

1693

5682

6665

4071

5879

9194

7

5

7

4

1

2

SEQUENCE+ECL Run
#593
SEQUENCE+ECL Run
#596
SEQUENCE+ECL Run
#600

RSD

1

22ECL

2ECL 3+4-4ECL 4ECL

2BR: 24853 89037
3BR:

Branch Reference all gal
REF
REF
REF

5

Total
seq Total ref

113890 107297

103669 335795

439464 432599

4BR:
94169 265286 359455 373672
Areas normalized to internal standard (I.S.) within the data set. A correction factor was
achieved by dividing the I.S. area in each run by highest I.S. within data set. The glycan
area was then multiplied by corresponding this correction factor.
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Table 2.10 Figure 2.4 raw peak areas for α2-6 sialic acid structural assignments
using multiple enzyme in α-1-acid glycoprotein sample 1.

I.S.
SEQUENCE -ECL Run
#584
SEQUENCE -ECL Run
#587
SEQUENCE -ECL Run
#590
AVERAGE
STDEV
RSD

2

3

4

5

34631 26891

199229

127749

306687

270631

35090 22347

181777

132156

291294

261339

33451 23798

185388

122375

283961

248143

34391 24345

188798

127427

293981

260038

846 2321

9212

4898

11599

11300

5

4

4

4

2

1

10
1ECL

2ECL

4ECL

32091 22229

99121

91478

93899 385078 335836 607

30246 20649

83921

74919

85946 356725 310311 610

27794 21424

83376

75692

76452 294739 250280 538

AVERAGE

30044 21434

88806

80696

85432 345514 298809

STDEV

2156 790

8937

9345

8735 46201 43922

10

12

SEQUENCE +ECL Run
#593
SEQUENCE +ECL Run
#596
SEQUENCE +ECL Run
#600

RSD

7

4
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Branch Reference all gal
REF
REF
REF

10

13

15

2.3.6 Working range of specific sialidase for an asparagine linked glycan mixture.
Although the AGP was a commercial standard, the amount of N-glycan present in the
sample was reported as total N-glycan mass, but the concentration of each branched
structure was not specified by the manufacturer. The bands of different N-glycans in the
AGP sample, which passed through the enzyme zones at different velocities and times,
were adjusted to maintain the enzyme working range established for the triantennary
standard. The AGP sample was diluted so that the total peak area of triantennary Nglycan of the AGP sample matched the peak area of the triantennary standard used in
Figure 2.2. While the areas of the tetraantennary and triantennary AGP N-glycans were
similar, the area of biantennary N-glycan was 4-fold lower. As a result, the applicability
of the working range for the AGP sample was validated.

The working range of α2-3 sialidase was established as described for the triantennary
standard. Three replicates of in-capillary digestions were performed at α2-3 sialidase
concentrations of 750 μUnits/µL and 250 μUnits/µL (Figure 2.5 and normalized areas in
Table 2.11 and raw areas in Table 2.12) and the distribution of desialylated peaks
compared. The peaks produced by these in-line enzyme reactions had reproducible
migration times and areas, with the relative standard deviation less than 1% and less than
10%, respectively. The areas of the product peaks obtained at these two concentrations
were not significantly different at a 0.01 significance level when compared using a twosided pooled T test. When lectin with high specificity to α2-3 sialic acids (MAL) was
included in the capillary no statistical difference in areas, which further confirmed that the
α2-3 sialic acids were completely cleaved from the sample. A lower concentration of α2-
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3 sialidase, 50 μUnits/µL, showed incomplete cleavage of α2-3 linked sialic acid. Two
different instruments were used for the sialic acid analysis and the range study. However,
the ratio of N-glycan to internal standard was the same because the same concentrations
were used (Table 2.13).

Figure 2.5 Establishing the working range of α2-3 sialidase enzyme
concentration for α-1-acid glycoprotein sample 1
This is defined by complete conversion of α2-3 sialic acids in-capillary
and averting enzyme specificity for α2-6 sialic acids. Separations
performed at 23 °C in a 25µm i.d. capillary, with an effective of 50cm
and E=450V/cm (reverse polarity). Pre-separation done at 4 kV for
9min to drive substrate past enzyme plug. The α2-3 sialidase is
suspended in 20% nanogel buffered with 50mM pH5 sodium acetate.
Reproduced with permission from: Bwanali, L.; Newton, E.; Crihfield,
C. L.; Zeger, V.; Gattu, S.; Holland, L. A., Quantification of the α2-6
sialic acid linkage in branched N-glycan structures with capillary
nanogel electrophoresis. Analytical Chemistry. 2020, 92 (1), 15181524. Copyright © 2019 American Chemical Society.
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Table 2.11 Figure 2.5 normalized areas of α2-3 sialidase working concentration range
for α-1-acid glycoprotein sample 1.
1
750 µUnits/µL
Run #1071
750 µUnits/µL
Run #1074
750 µUnits/µL
Run #077
AVERAGE
RSD

2

3

4

5

6

7

8

9

10

11

12

13

Total

0

68027 407593 121126 23371 96239 130271 43141 109180 54227 26541 344749 107522 1531986

0

65741 404379 118955 23429 94472 127878 42543 107962 53814 25638 339717 105471 1509999

0

66208 407140 119798 23651 94748 129568 42215 108624 53392 26189 342045 105397 1518975

0
0

66659 406371 119960 23483 95153 129239 42633 108589 53811 26122 342170 106130 1520320
0
0
1
1
1
1
1
1
1
2
1
1
1

0

67988 407005 121080 22759 95035 130043 41894 108123 48608 24841 307259 106679 1481312

0

67881 405572 120146 22363 94302 128824 42388 108678 49215 24362 336612 103797 1504142

0

68088 408465 120779 22907 94715 129721 42244 109521 50061 25095 338845 103975 1514416

AVERAGE

0

67985 407014 120668 22676 94684 129529 42175 108774 49295 24766 327572 104817 1499957

RSD

0

250 µUnits/µL
MAL Run
#1043

0

250 µUnits/µL
Run #1062
250 µUnits/µL
Run #1065
250 µUnits/µL
Run #1068

50 µUnits/µL
Run #1047

0

0

0

1

0

0

1

1

1

2

5

2

1

64753 416838 122607 21539 97298 130189 41510 111004 45528 23926 344927 105494 1525612

54462 59894 423343 79404 20551 90541 127230 24409 138843 45595 10585 299277 66739 1440871

Areas normalized to internal standard (I.S.) within the data set. A correction factor was
achieved by dividing the I.S. area in each run by highest I.S. within data set. The glycan
area was then multiplied by corresponding this correction factor.
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Table 2.12 Figure 2.5 raw areas of α2-3 sialidase working concentration range for α-1-acid
glycoprotein sample 1.
750 µUnits/µL
Run #1071
750 µUnits/µL
Run #1074
750 µUnits/µL
Run #1077
AVERAGE
RSD

I.S

1

59897

0

67982 407321 121045 23355 96175 130184 43112 109107 54191 26523 344519 107450 1530964

59937

0

65741 404379 118955 23429 94472 127878 42543 107962 53814 25638 339717 105471 1509999

58622
59485
1

0
0
0

64755 398207 117170 23132 92669 126725 41289 106241 52221 25614 334541 103085 1485649
66159 403302 119057 23305 94439 128262 42315 107770 53409 25925 339592 105335 1508871
2
1
2
1
2
1
2
1
2
2
1
2
2

0

67890 406421 120906 22726 94899 129856 41834 107968 48538 24805 306818 106526 1479187

0

67805 405119 120012 22338 94197 128680 42341 108557 49160 24335 336236 103681 1502461

0

67421 404465 119596 22683 93787 128451 41830 108448 49571 24849 335526 102957 1499584

59690

0

67705 405335 120171 22582 94294 128996 42002 108324 49090 24663 326193 104388 1493744

0

0

250 µUnits/µL
Run #1062
59851
250 µUnits/µL
Run #1065
59870
250 µUnits/µL
Run #1068
59350
AVERAGE
RSD

250 µUnits/µL
MAL RAW 1043 59846
50 µUnits/µL
RAW 1047

0

2

0

3

0

4

1

5

1

6

1

7

1

8

1

9

0

10

1

11

1

12

5

13

2

Total

1

64655 416205 122421 21506 97150 129991 41447 110835 45459 23890 344403 105334 1523296

59501 54066 59458 420263 78826 20402 89882 126304 24231 137833 45263 10508 297100 66254 1430390

Table 2.13 Comparison of α-1-acid glycoprotein sample 1
glycan area to internal standard area across instruments for each
enzyme condition.
Ratio
I.S.
Glycan
glycan
area
area
area to IS Instrument
AGP sample 1
α2-3 sialidase range
study
34000 895000
26
2
Multiple enzyme
sequencing study
60000 1490000
25
1
Internal standard (I.S.) and glycan areas are averages of 3
replicates performed on each instrument. The total glycan area
was divided by total standard area.
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2.3.7 Enzyme processing.
Serial enzyme processing was then applied to the AGP N-glycans to identify the α2-6
linked sialic acid distribution. The migration windows for the bi-, tri- and tetraantennary
peaks with different numbers of galactose residues are emphasized with arrows in Figure
2.4A. The enzyme processing was performed in the absence (Figure 2.4B black trace)
and presence (Figure 2.4B blue trace) of lectin with affinity to galactose bearing structures
(i.e. ECL) to distinguish any comigrating peaks. From these runs areas were determined
by assigning the biantennary structures to peaks until the summed area for biantennary
peaks equaled the corresponding area established from the reference traces in Figure
2.4A. This process was repeated for the triantennary and then for the tetraantennary
structures. Peak splitting observed with the triantennary standard (Figure 2.4B) due to
differences in the α1-3 and α1-6 arm mannose linkages in the core were also observed
in the AGP mixture (Figure 2.4B, black trace) for the mono-galactosylated structures that
are biantennary (19.6 min, 19.9 min), triantennary (20.8 min, 21.1 min), and
tetraantennary (22.1 min, 22.4 min). The agalactosylated biantennary peak (18.6 min) is
broad because some of the biantennary N-glycans were partially desialylated and
differences in mobility of the fully and partially sialylated structure induced this
broadening.

2.3.8 Comparison of the α2-6 sialic acid content from different sources of α-1 acid
glycoprotein.
A second sample, which was a commercially available source of free N-glycans cleaved
from AGP, was analyzed with the same method to determine α2-6 sialic acid composition.
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The second AGP sample was diluted so that the total peak area of triantennary N-glycan
of the AGP sample matched the peak area of the triantennary standard used in Figure
2.2. The areas of the biantennary and tetraantennary N-glycan peaks were 1.4-fold and
2.3-fold lower than that of the triantennary N-glycan. The working range of α2-3 sialidase
was confirmed as shown in Figure 2.6 and the area of each branched structure was
normalized to the internal standard (Figure 2.6 and Table 2.14 for normalized areas and
Table 2.15 for raw areas). Two different instruments were used for the sialic acid analysis
and the range study. However, the ratio of N-glycan to internal standard was the same
because the same concentrations were used, as shown in Table 2.16.

Figure 2.6 Establishing the working range of α2-3 sialidase enzyme
concentration for α-1-acid glycoprotein sample 2.
This is defined by complete conversion of α2-3 linked sialic acids incapillary with no cleavage of α2-6 linked sialic acids. Separation
conditions as described in Figure 2.4. Structures cannot be
assigned with of α2-3 sialidase only. Reproduced with permission
from: Bwanali, L.; Newton, E.; Crihfield, C. L.; Zeger, V.; Gattu,
S.; Holland, L. A., Quantification of the α2-6 sialic acid linkage in
branched N-glycan structures with capillary nanogel electrophoresis.
Analytical Chemistry. 2020, 92 (1), 1518-1524. Copyright © 2019
American Chemical Society.
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Table 2.14 Figure 2.6 normalized areas of α2-3 sialidase working concentration range for
α-1-acid glycoprotein sample 2.
1
750 µUnits/µL Run
#448
750 µUnits/µL Run
#451
750 µUnits/µL Run
#454
AVERAGE
RSD
250 µUnits/µL Run
#436
250 µUnits/µL Run
#442
250 µUnits/µL Run
#445
AVERAGE
RSD
250 µUnits/µL MAL
Run #439
50 µUnits/µL Run
#298

2

3

4

5

6

7

8

9

10

11

Total

0

27986 186526 89891 32702 42475 20238 31688 13596 185464 49213 679778

0

28777 192623 93719 33134 43179 21688 32807 14116 185029 49903 694975

0
0
0

26669 183238 86878 33253 44381 22827 31904 14359 190627 47845 681981
27811 187462 90163 33029 43345 21584 32133 14024 187040 48987 685578
4
3
4
1
2
6
2
3
2
2
1

0

28085 190622 88866 32406 42498 20537 32928 14538 177524 46827 674831

0

27234 187851 85706 32229 42155 19364 34408 14735 178743 45535 667960

0
0
0

27867 182362 85277 33122 42906 19079 36516 14108 182552 42917 666707
27729 186945 86616 32585 42520 19660 34617 14461 179606 45093 669833
2
2
2
1
1
4
5
2
1
4
1

0

26358 187942 87524 31643 42285 19238 34878 11222 175007 47094 663191

42296 19904 195582 53183 31606 41956 12870 44278 10904 176514 28898 657991

Areas normalized to internal standard (I.S.) within the data set. A correction factor was
achieved by dividing the I.S. area in each run by highest I.S. within data set. The glycan
area was then multiplied by corresponding this correction factor.
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Table 2.15 Figure 2.6 raw areas of α2-3 sialidase working concentration range for α-1acid glycoprotein sample 2.
1
750 µUnits/µL Run
#448
750 µUnits/µL Run
#451
750 µUnits/µL Run
#454
AVERAGE
RSD
250 µUnits/µL Run
#436
250 µUnits/µL Run
#442
250 µUnits/µL Run
#445
AVERAGE
RSD
250 µUnits/µL
MAL Run #439

2

3

4

5

6

7

8

9

10

11

Total

35305

0

25440 169558 81714 29727 38611 18397 28805 12359 168593 44736 617940

33526

0

24841 166277 80901 28602 37273 18722 28320 12185 159722 43078 599921

34677
34503
3

0
0
0

23812 163606 77570 29690 39626 20381 28486 12821 170204 42719 608915
24698 166480 80062 29340 38503 19167 28537 12455 166173 43511 608925
0
2
3
2
3
6
1
3
3
2
1

37125

0

26846 182214 84946 30977 40624 19631 31476 13897 169694 44762 645067

36215

0

25395 175164 79918 30052 39308 18056 32084 13740 166671 42460 622848

29323
34221
12

0
0
0

21040 137685 64385 25007 32394 14405 27570 10652 137828 32403 503369
24427 165021 76416 28679 37442 17364 30377 12763 158064 39875 590428
12
15
14
11
12
15
8
14
11
16
13

36287

0

24627 175597 81775 29565 39508 17974 32587 10485 163512 44001 619631

50 µUnits/µL Run
#298
38838 42296 19904 195582 53183 31606 41956 12870 44278 10904 176514 28898 657991

Table 2.16 Comparison of α-1-acid glycoprotein sample 2
glycan area to internal standard area across instruments for
each enzyme condition
76

I.S.
area

Glycan
area

Ratio
glycan
area to IS Instrument

AGP Sample 2
α2-3 sialidase range
study
79000 1750000
22
1
Multiple enzyme
sequencing study
34000 677000
20
2
Internal standard (I.S.) and glycan areas are averages of 3
replicates performed on each instrument. The total glycan area
was divided by total standard area.

The second sample contained more unreacted APTS than sample 1. Additionally, the
total glycan area of the second sample was approximately 2.4 times higher than that of
sample 1, shown in Figure 2.7. As a result, more contaminant peaks, (which are labeled
with an asterisk in Figures 2.7), were evident in the second sample. The contaminant
peaks were distinguishable from the N-glycan peaks by comparing the signal obtained
from serial enzyme processing performed in the absence and presence of ECL (Figure
2.8).
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Figure 2.7 Analyses of α-1-acid
glycoprotein sample 2 asparaginelinked glycans.
The glycans were obtained from a
different source than that shown for
Figure 2.3. (A) reference traces
establish the area associated with
biantennary, triantennary, and
tetraantennary glycans. (B) The α2-6
linked sialic acid area of each
branched structure is established
through serial enzyme processing in
the absence of ECL (black trace).
Presence of ECL (blue trace) identifies
agalactosylated glycans in comigrating peaks. Separation
conditions are as specified in Figure
2.2. The asterisk denotes
contaminant peaks. Reproduced with
permission from: Bwanali, L.;
Newton, E.; Crihfield, C. L.; Zeger,
V.; Gattu, S.; Holland, L. A.,
Quantification of the α2-6 sialic acid
linkage in branched N-glycan
structures with capillary nanogel
electrophoresis. Analytical Chemistry.
2020, 92 (1), 1518-1524. Copyright ©
2019 American Chemical Society.
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Figure 2.8 Identification of glycan and contaminant peaks in Figure 2.7.
Peak that respond to ECL are glycans. Peaks that do not respond to ECL
(grey box) are contaminants. Reproduced with permission from: Bwanali,
L.; Newton, E.; Crihfield, C. L.; Zeger, V.; Gattu, S.; Holland, L. A.,
Quantification of the α2-6 sialic acid linkage in branched N-glycan
structures with capillary nanogel electrophoresis. Analytical Chemistry.
2020, 92 (1), 1518-1524. Copyright © 2019 American Chemical Society.

Although different branching ratios were observed for sample 1 as compared to sample
2 for the biantennary (13% vs 21%), triantennary (51% vs 47%), and tetraantennary (36%
vs 31%) structure, these branching distributions were within the ranges reported in the
literature.6, 31, 32 Interestingly, the predominant form of α2-6 sialic acid in each branched
structure contained only a single α2-6 sialic acid. Small amounts of tetraantennary Nglycan containing two to four α2-6 sialic acids were observed (Table 2.17).

The

normalized and raw areas are shown in Table 2.18 and 2.19). This was expected as α23 sialic acids adopt an extended linear conformation; whereas, α2-6 sialic acids are
oriented toward the mannose core forming a more compact glycan structure.27 Although
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quantification of α2-6 linked sialylation in AGP had not previously been reported, AGP
has been reported to contain monogalactosylated,8 as well as di-, and tri-galactosylated
tetraantennary structures.33

Table 2.17 Peak area of α2-6 linked sialic from α-1-acid
glycoprotein sample 2 glycans.
3
α2-6 linked sialic acid ( ) area x 10 (%RSD)
Branch
0
1
2
3
4
Total
56(1) 339(3)
0
395(3)
⎯
⎯
226(3) 649(6)

0

216(5) 339(6) 19(10)

0
52(7)
3

⎯

876(7)

19(10) 645(6)

Areas are reported in units of 10 RFU. The areas and
percent relative standard deviation (RSD) of 2, 3, and 4
branch N-glycans from alignment trace normalized to internal
standard are: 380 (2), 890 (4), and 630 (4), respectively.
Normalization is based on the highest quantified area for the
internal standard within the alignment traces, sequencing
traces, and sequencing traces with ECL (i.e. 81,675 RFU).
Solid lines in the table indicate that the structure not possible.
Separation conditions are as stated Figure 2.2.

80

Table 2.18 Figure 2.7 normalized peak areas for α2-6 sialic acid structural
assignments using multiple enzyme in α-1-acid glycoprotein sample 2.

SEQUENCE -ECL Run
#436
SEQUENCE -ECL Run
#439
SEQUENCE -ECL Run
#442
AVERAGE
STDEV

1

2

3

4

56455

565832

288914

559491

319106 17009 51319 18766

55481

571225

301427

585017

356330 20918 55103 21107

54975

560688

297290

563324

340401 19102 48317 17467

55637

565915

295877

569278

338612 19010 51579 19113

6375

13765

752

RSD

1

SEQUENCE +ECL Run
#445
SEQUENCE +ECL Run
#431
SEQUENCE +ECL Run
#434
AVERAGE
STDEV

5269
1

2

7

8

18676

1956

3400

1844

6

10

7

10

2

2ECL

4ECL

53605

229706

223903

54317

218287

204900

56391

232093

220000

REF
373336 854439 607008 538
REF
381305 891447 635965 535
REF
385512 923288 659665 531

54771

226695

216267

380051 889725 634213

1448

7379

10036

3

3

5

1

2-2ECL 2ECL 3+4-4ECL

4ECL

2BR: 55637 339219

4BR:

6

1

RSD

3BR:

5

Branch Reference all gal

6184
2

5

6

7

8

34456 26372
4

4

total
seq total ref
394856 380051

226695

648887

875583 889725
216267 338612 19010 51579 19113 644582 634213

Areas normalized to internal standard (I.S.) within the data set. A correction factor was
achieved by dividing the I.S. area in each run by highest I.S. within data set. The glycan
area was then multiplied by corresponding this correction factor.
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Table 2.19 Figure 2.7 raw peak areas for α2-6 sialic acid structural
ssignments using multiple enzyme in α-1-acid glycoprotein sample 2.

I.S.
1
SEQUENCE -ECL
Run #436
79148 54708
SEQUENCE -ECL Run
#439
77574 52695
SEQUENCE -ECL Run
#442
78756 53010
AVERAGE
STDEV
RSD

78493 53471
819 1083
1

2

1
SEQUENCE +ECL
Run #445
SEQUENCE +ECL
Run #431
SEQUENCE +ECL
Run #434
AVERAGE
STDEV
RSD

2

3

4

540649

279975

542181

309233 16483 49731 18185

540649

286292

555643

338438 19868 52336 20047

540649

286665

543191

328235 18419 46590 16843

543839

284311

547005

325302 18257 49552 18358

3999

3759

1

5

7498

1

1

6

7

8

14822

1698

2877

1609

5

9

6

9

2ECL

4ECL

78669 51632

221252

215662

79037 52563

211237

198282

75522 52143

214608

203426

REF
368171 842618 598610 80545 538
REF
381305 891447 635965 81675 535
REF
392229 939374 671158 83098 531

77743 52113

215699

205790

380568 891146 635244
12046 48379 36279

Branch Reference all gal

1932

466

5096

8928

2

1

2

4

3

5

IS

6

2.4 Conclusions and future directions
Quantification of the amount of α2-6 sialic acid in N-glycan structures was achieved using
an enzyme based method of glycan modification. With the use of nanogel, enzymatic
conversion of N-glycans was achieved in real-time and consumed only nanoliter volumes
of enzymes or lectins for each analysis. Capillary electrophoresis analyses of mixtures
of sialylated N-glycans are complex because of the charge on the sialic acids.
Additionally, N-glycans can be desialylated when exposed to heat and/or to different
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solutions used in conventional sample processing. Moreover, differences in the stability
of α2-6 vs α2-3 linked sialic acids are found in the literature. By incorporating the
enzymes as outlined in this report, a predictable mobility shift based on a change in the
charge-to-size ratio of the N-glycan was achieved. With this method, the α2-6 linked sialic
acid linkage of N-glycans was determined for a pure standard as well as for mixtures of
biantennary, triantennary, and tetraantennary structures derived from AGP. Moreover,
the exact site of exact site of α2-6 linked sialylation in biantennary and potentially
triantennary N-glycans can be inferred based on the difference in hydrodynamic radius
for the α1-3 mannose, which is more extended,29 creating a larger hydrodynamic radius
and a slower electrophoretic migration in the electric field observed in capillary
electrophoresis separations of N-glycans.34-36 Determination of sialic acid linkage is
critical to validating ongoing research on the use of α2-6 linked sialic acid as a biomarker
of disease. Future work centers on the application of this technology to glycoproteins as
well as glycan standards to authenticate the degree of sialylation and sialic acid linkage.
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Chapter 3 : Capillary Nanogel Electrophoresis for the
Determination of the β1-4 Galactosyltransferase MichaelisMenten Constant and Real-Time Addition of Galactose
Residues to N-Glycan and Glycoprotein

Reproduced from

Bwanali, L.; Holland, L. A., Capillary Nanogel Electrophoresis for the Determination of
the β1-4 Galactosyltransferase Michaelis-Menten Constant and Real-Time Addition of
Galactose Residues to N-Glycan and Glycoprotein. Analytical Chemistry. Submitted
June 2021.
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3.1 Introduction
Protein-based drugs comprise a new generation of pharmaceuticals that improve human
health. Prior to the 2019 pandemic, the therapeutic antibody market was projected to
reach an annual value of 300 billion USD in 2025.1 However, this projection is subject to
change given the dramatic development and use of monoclonal antibody therapeutics to
treat COVID19.2 IgG antibodies contain asparagine-linked glycans (N-glycans) in the CH2
domain, and these N-glycans modulate receptor interactions integral to immune
response.3, 4 Glycosylation, which is a critical quality attribute of protein therapeutics, 5 is
a non-templated post-translational modification controlled by enzymes. Modifications to
IgG glycosylation influence the antibody effector function6, 7 as well as pharmacokinetics.8
Several strategies have been developed to control enzymatic processing through
engineered cell lines,9-11 and post-expression chemoenzymatic processing.12,

13

Enzymatic modifications of glycoproteins have been demonstrated with wild type and
mutant enzymes,6, 7 and a variety of designer enzymes have been customized to tailor
glycosylation.13, 14 For example, one -1,4-galactosyltransferase, GalT(Y289), enables
custom antibody modification15 through click16 chemistry. Although enzymes can be
developed through structurally guided point mutations, they must ultimately be screened
and characterized to quantify the performance of the enzyme-substrate system.

Galactosyltransferase assays require a means to detect the products, and generally rely
on modifying either the donor or the acceptor with a radiochemical label or
chromophore.17 Because both the reactants and products are detectable they must be
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distinguished prior to quantification. This has been accomplished with techniques such
as chromatography or mass spectrometry. Commercial kits are available and for some
kits a secondary reaction occurs which renders the products detectable in the presence
of optically inactive reactants. Enzyme assays have been adapted for higher throughput
platforms, for example through microarrays, multi-well plates, or through analyses in
series. A consideration for these methods is the amount of enzyme consumed for each
determination when multiple analyses are conducted.

Ultimately, strategies to

characterize transferase enzymes require technologies that are both fast and automated.
Additionally, they should be compatible with low substrate and enzyme volumes given the
effort required for enzyme expression and the cost of different substrate-donor pairs.

Capillary electrophoresis is an easily automated microscale method of analysis that
consumes picoliter to nanoliter sample volumes. Moreover, capillary electrophoresis is
amenable to in-capillary analyses that integrate the enzyme assay with a separationbased detection for product quantification. Several strategies have been reported to
immobilize enzymes in the separation capillary,18,

19

including covalent immobilization

methods based on the use of monoliths20 or particles,21 which generate high surface area
to load enzymes. Alternatively, enzymes can be noncovalently immobilized directly onto
unmodified22 or surface-modified capillaries.23 The ease of noncovalent immobilization
and the advantage of high loading capacity has been realized through the use of
noncovalently immobilized enzyme reactors based on self-assembled materials for
entrapment, such as hydrogels24 and nanogels.25-27
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Nanogels are non-Newtonian fluids composed of phospholipids that self-assemble to
form different morphologies with a temperature-dependence.28, 29 Nanogels have a low
viscosity at low temperature (i.e., 19 °C) and a gel-like viscosity at temperatures of 25 °C
and higher, allowing for introduction in capillary at low temperature. Once the nanogel is
loaded into the separation capillary, the temperature is then raised to create a gel-like
viscosity, to enhance the enzyme reaction and the separation. Separations of complex
samples of N-glycans have been described with the use of nanogels as a viscous additive
in capillary electrophoresis.30, 31 Nanogels have been used to pattern biological reagents
in the capillary for N-glycan sequencing and for structural identification.25-27, 30 When the
nanogel separation is complete easily the nanogel is expelled and then fresh nanogel are
repatterned by dropping the temperature, after and the capillary is patterned with fresh
biological reagents for a new run to be completed. Nanogels have been used to pattern
enzyme reactions in-capillary prior to the separations, enabling the determination of
Michaelis-Menten

values,27

structural

identification

of

N-glycans,32,

33

and

oligosaccharide linkage analyses.25, 26 There are several advantages to using nanogels
for enzyme reactions including enhanced enzyme stability,27 precise control of the size
and position of the enzyme zone,25,
conditions.25,

27

27

as well as flexibility in the reaction zone

The use of nanogels in enzyme analyses has been limited to

exoglycosidase trimming of different N-glycan substrates.25-27,

32, 33

Transferase

reactions, which are more complex, require the presence of a donor, acceptor, and often
a cofactor. Nanogel patterning offers an opportunity to pattern and integrate a more
complex reaction system in an automated microscale format.
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To date, most capillary electrophoresis analyses of galactosyltransferase (GalT) have
been used for off-line enzyme assays performed as benchtop reactions.34-37 In this study,
nanogels were used to pattern the uridine-5ʹ-diphosphogalactose (UDP-gal) donor, GalT
and manganese cofactor to transfer galactose to oligosaccharides as shown in Figure
3.1. A labeled glycan substrate was driven electrophoretically through the reaction zone
which was located within the thermally regulated portion of the capillary. Once the
enzyme-catalyzed conversion was complete, the reaction products were separated and
quantified.

A pentasaccharide end-labeled with 2-aminobenzoic acid was used to

evaluate the system as this molecule was representative of the biantennary structure of
an N-glycan.

With the ability to distinguish reaction products for which either one or two

galactose residues were transferred (see Figure 3.1), the capillary nanogel
electrophoresis system was used to determine the Michaelis-Menten value, KM. The
Michaelis-Menten constant for the addition of a single galactose residue was derived by
plotting the velocity of product formation against the concentration of pentasaccharide
introduced into the capillary. For the β1-4 galactosyltransferase, the KM value obtained
for a pentasaccharide substrate was 1.23 ± 0.08 mM. Once the KM was established, the
enzyme-to-substrate ratio was evaluated to add a single galactose residue, or to fully
galactosylate a biantennary N-glycan. Fluorescently labeled biantennary N-glycans were
used to determine the relationship between the enzyme-to-substrate ratio and the amount
of galactose transferred. By utilizing fluorescence detection, a lower concentration of
substrate was observed, which facilitated experiments with ratios of enzyme:substrate.
Ratios of enzyme:substrate were successively increased in the reaction zone until a
change in the distribution of galactosylation of the reaction products was observed.
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Figure 3.1 Conceptual diagram illustrating the online reaction where the
transferase enzyme adds a monomer to an acceptor biantennary glycan,
pentasaccharide, that has been end labeled with aminobenzoic acid.
The figure shows how the patterning in the capillary is achieved, together with a
concept trace showing how different degrees of galactosylation are identified.
After identifying the galactosylation the concept is used to achieve the KM of the
pentasaccharide with the enzyme β1-4 galactosyltransferase. Reproduced with
permission from: Bwanali, L.; Holland, L. A., Capillary Nanogel Electrophoresis
for the Determination of the β1-4 Galactosyltransferase Michaelis-Menten
Constant and Real-Time Addition of Galactose Residues to N-Glycan and
Glycoprotein. Analytical Chemistry. Submitted June 2021.

Finally, the integrated nanogel separation was modified to transfer galactose residues to
an intact glycoprotein. The applicability of the method for real-time online modification of
whole protein was demonstrated with the Herceptin glycoprotein. Complete retardation
by Erythrina Cristagalli lectin after enzymatic modification confirmed the addition of
galactose residues to the Herceptin. This demonstrated the potential of the method to be
used for online modification of other glycoproteins.
.
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3.2 Materials and methods
3.2.1 Chemicals and reagents.
The

8-aminopyrene-1,3,6-trisulfonic

acid

(APTS),

-1,4-galactosyltransferase

(SAE0093), 2-aminobenzoic acid (118-92-3), UDP-α-D-galactose, disodium salt (67011110MG-M), methanol, ethanol, 3-(N-morpholino)-propanesulfonic acid (MOPS), sodium
cyanoborohydride (either 296813, 1.0 M dissolved in tetrahydrofuran or 156159), sodium
acetate and sodium hydroxide were from Sigma-Aldrich (St. Louis, MO). Acetic acid was
from Fisher Scientific (Pittsburgh, PA). Manganese (II) chloride tetrahydrate (13446-349) was obtained from Alfa Aesar (Haverhill, MA). Erythrina Cristagalli lectin (ECL), was
from Vector Labs (Burlingame, CA). PNGase F was purchased from New England
Biolabs (Ipswich, MA). 18.2 MΩ-cm deionized water produced from an Elga Purelab ultra
water system (Lowell, MA) was utilized. The biantennary N-linked core pentasaccharide
was from Dextra Laboratories Ltd (Bristol, UK). The phospholipids 1,2-dimyristoyl-snglycero-3-phosphocholine (DMPC) and 1,2-dihexanoyl-sn-glycero-3-phosphocholine
(DHPC), were from Avanti Polar Lipids (Alabaster, AL). Nanogels were prepared by
weighing phospholipids and combining them such that [DMPC]/[DHPC] = 2.5.

The

phospholipids were dissolved in an aqueous solution of 100 mM MOPS buffered to pH of
7.0 to achieve concentrations of 10, 20 and 30% preparations.
reconstitute phospholipids has been described previously.32,

33

The process to
Once made, each

preparation was then aliquoted and stored at −20 °C. for up to 10 days.
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3.2.2 Preparation and derivatization of standards.
The glycans were labeled with a fluorescent or UV absorbing chromophore as previously
described.27, 30, 32, 33 Prior to labeling, the biantennary N-glycans were cleaved from the
glycoprotein as described previously.32 Briefly, the labeling reaction was performed at
37°C overnight with a ratio of 500 nanomoles 8-aminopyrene-1,3,6-trisulfonic acid
(APTS): 10 nanomoles biantennary N-glycans by reacting 2.5 μl volume of 4 mM
biantennary N-glycans dissolved in 1 M sodium cyanoborohydride in tetrahydrofuran with
2.5 μl volume of 0.2 M APTS dissolved in 20% acetic acid. Once the reaction was
completed the reaction mixture was evaporated to dryness using a Savant SpeedVac
concentrator (ThermoScientific, Waltham, MA) and excess APTS was removed from the
labelling reaction using a Discovery DPA-6S solid phase extraction cartridge (52624-U
50 mg packing material, Supelco, Bellefonte, PA) as previously described. 30 Prior to
analysis glycan samples were diluted in 1 mM MOPS buffered to pH 7.

The determination of the KM in the mM range required that the substrate was labeled with
the 2-aminobenzoic acid chromophore detected by UV-visible absorbance. The substrate
labeling procedure was previously developed and reported27 to ensure complete labeling
of the substrate as residual unlabeled substrate would bias the KM measurement. Briefly,
the labeling reaction was performed at a ratio of 1400 nanomoles 2-aminobenzoic acid:
200 nanomoles pentasaccharide by reacting 1 μl volume of 0.2 M saccharide dissolved
in water with 1 μl volume of 1.39 M 2-aminobenzoic acid and 23 μl volume of 1 M sodium
cyanoborohydride both of which were dissolved in 0.5 M acetic acid (obtained by diluting
glacial acetic acid with methanol). The reaction proceeded at 65°C for 2 hours. Once
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the reaction was completed the reaction mixture was evaporated to dryness using a
Savant SpeedVac concentrator (ThermoScientific) and excess 2-aminobenzoic acid was
removed from the labelling reaction using a Discovery DPA-6S solid phase extraction
cartridge (52624-U Supelco) as previously described.27 Briefly, the saccharide solution
was diluted to ensure a final composition of 95% acetonitrile prior to the purification
process. The DPA-6S solid phase extraction cartridge tube was loaded with 1-mL of the
sample diluted to contain 95:5 (v/v) acetonitrile:deionized water. The 1-mL flow-through
captured during the initial sample loading was reloaded onto the cartridge twice. Once
loaded in the extraction cartridge, the 2-aminobenzoic acid was eluted using 10-mL of a
solution comprised of 95% acetonitrile, 5% deionized water that also contained 1 mM
triethylamine. Next, the retained glycans were eluted from the cartridge using 3-mL of a
solution of 25 mM triethylamine in deionized water. Following purification, the fraction
containing labeled oligosaccharide was dried using a SpeedVac concentrator,
reconstituted in 25 L deionized water, and stored at -20 °C. Prior to injection, sample
was diluted in 1 mM MOPS buffered to pH 7. The pentasaccharide was analyzed before
and after purification and 100% recovery was demonstrated as shown in Figure 3.2
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Figure 3.2 Before and after cleanup samples of 2-aminobenzoic acid labeling reaction.
500 uM pentasaccharide was injected at 1 PSI for 5 s .

3.2.3 Preparation of enzyme and lectin.
The GalT enzyme was reconstituted so that the appropriate concentration of enzyme was
in 10% phospholipid buffered at pH 7 with 100 mM MOPs. The enzyme zones were
buffered at pH 7, which was compatible with enzyme conversion 38 and was near the
enzyme isoelectric point of 8.75.39 For the GalT enzyme 1 Unit was defined as the amount
of enzyme required to transfer 1.0 nanomole of galactose from UDP-Gal to GlcNAc per
minute at pH 7.5, 37 °C.40 The ECL Lectin was desalted prior to use. The salts were
removed using a 10 kDa molecular weight cut off filter centrifuged at 14,000G and 19 °C.
The ECL was rinsed by centrifuging 3 times each at 10 minutes with a 0.5 mL solution of
100 mM MOPS buffered to pH 7. Once desalted, the ECL was mixed 1:1 with a 20%
99

nanogel preparation that contained 100 mM MOPS buffered to pH 7.

The final

concentration of the ECL was 100 μM ECL in 10% nanogel.

3.2.4 Capillary electrophoresis.
Analyses were performed using a SCIEX MDQ Plus (Sciex, Redwood City, CA)
configured by the manufacturer with laser induced fluorescence detection and appropriate
filters (3 mW solid state laser with λex = 488 nm, λem = 520 nm) and a UV-visible
absorbance detector (monitored at 214 nm). Silica capillaries with a 25 μm internal
diameter and 360 μm outer diameter fused silica capillary (Polymicro Technologies,
Phoenix, AZ) were used for the separations. The electrophoresis was performed using
reversed polarity to separate the negatively-charged amino benzoic acid-labeled, or
APTS-labeled glycans (anodic reservoir near detector, cathodic reservoir near the site of
injection). Ambient thermal control of the room and instrument was maintained using a
portable air conditioner as was described previously.31

The electrophoresis was

performed using reversed polarity in combination with a semi-permanent coating41 to
suppress the electroosmotic flow to separate the negatively-charged amino benzoic acidlabeled, or APTS-labeled glycans (anodic reservoir near detector, cathodic reservoir near
the site of injection). Each day capillaries were prepared as previously described. 30 The
capillaries were prepared by flushing with the following sequence: 1 M NaOH for 30
minutes at 170 kPa (25 psi), deionized water for 15 minutes at 170 kPa (25 psi), 15
minutes methanol at 170 kPa (25 psi), and deionized water for 15 minutes at 170 kPa (25
psi). The capillary was then coated with q = 0.5, 5% phospholipid by weight (with
[DMPC]:[DHPC] = 0.5) containing 1.25 mM calcium for 20 minutes at 170 kPa (25 psi),
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followed by a 3 minute 170 kPa (25 psi) rinse with MOPS. Prior to each run the capillary
was held at 19 °C and the 10% nanogel was introduced in the capillary at 170 kPa (25
psi) for 8 minutes.

The amount of the cofactor manganese (II) chloride needed in the capillary for enzyme
conversion was established in order to achieve optimum conversion as shown in Table
3.1 and Figure 3.3. When the 5 mM cofactor was present only in the enzyme plug, 24%
of the substrate still remained with only one galactose added. When manganese (II)
chloride was incorporate to the left of the enzyme plug the conversion increased, and only
9% remained with only one galactose added. No further improvement in conversion were
realized when the enzyme plug was increased to 3 cm. Since this plug size did not
negatively impact the separation it was chosen for all enzymatic reactions. Manganese
(II) chloride at a higher concentration of 10 mM interacted with the lipid causing baseline
disturbance
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Figure 3.3 Impact of manganese zone on biantennary N-glycan conversion
5 mU/µL β1-3,4 galactosyltransferase is in nanogel was employed. When
manganese (II) chloride was used a concentration of 5 mM was maintained.
Pre-separation was done at 4 kV for 15 min to drive substrate past enzyme
o
plug. The separations was then performed at 20 kV at 29 C in a 25 um i/d.
capillary with effective length of 50cm and applied voltage of 20 kV (reverse
polarity)

Table 3.1 : Impact of manganese zone on biantennary N-glycan conversion
1 galactose
area (SD)

2 galactose
area (SD)

0 cm Manganese (II)
chloride
35,000 (4,000) 110,000 (10,000)
1 cm Manganese (II)
chloride
12,400 (600) 121,000 (1,000)
3 cm manganese (II)
chloride
11,400 (500) (124,000) (4,000)
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1 galactose
area % (SD)

2 galactose
area % (SD)

24 (3)

76 (2)

9 (0.3)

91 (0.1)

9 (0.1)

91 (0.1)

To convert the pentasaccharide in the online determination of the KM, reactions zones
were introduced in the capillary to achieve the patterning shown in Figure 3.4. Patterning
in the capillary was an automated process performed by the capillary electrophoresis
instrument in multiple steps. In the patterning for pentasaccharide analysis (data for
Figure 3.4 and 3.5), the capillary was first filled with the 10% nanogel. Secondly, the
MnCl2 zone was introduced at 68.9 kPa (10 psi) for 13 s followed by injection of the
enzyme plug at 68.9 kPa (10 psi) for 13 s. For the 40 cm capillary, it took a plug of 2
aminobenzoic acid 43.3 s to travel a distance of 10.2 cm when pushed at 10 psi by the
10% nanogel. A plug introduced for 4.25 s would be 1 cm long. Therefore, the MnCl2
and enzyme zones were 3 cm long. The UDP-gal was then introduced at 68.9 kPa (10
psi) for 19.5 s to achieve a 4.5 cm zone. Finally, a background electrolyte pre-plug of
13.8 kPa (2 psi) for 7 s was introduced. After the capillary was filled, the temperature of
the separation was increased to 29 °C for the sample injection, incubation, and
separation. Sample injections were at 10 kV 10 s followed by a background electrolyte
post-plug of 13.8 kPa (0.5 psi) for 5 s. After a run was complete, a 241 kPa (35 psi)
background electrolyte flush for 15 min was applied in the reverse direction to push out
any remaining enzyme toward the site of injection. Data collection and analyses were
performed using 32 Karat Software version 10.2.

In the patterning for the Herceptin N-glycan analysis the capillary was first filled with 10%
nanogel. The MnCl2 zone was then introduced at 68.9 kPa (10 psi) for 21 s followed by
injection of the enzyme plug at 68.9 kPa (10 psi) for 21 s. For the 60 cm capillary used
in this analysis, it took a plug of APTS 70 s to travel a distance of 10.2 cm when pushed
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at 10 psi with the 10% nanogel. A plug introduced for 6.9 s would be 1 cm long.
Therefore, the MnCl2 and enzyme zones were 3 cm long.

The UDP-gal was then

introduced at 68.9 kPa (10 psi) for 28 s (4 cm). Finally, a background electrolyte pre-plug
of 13.8 kPa (2 psi) for 7 s was introduced. Sample injections were at 10 kV 10 s followed
by a background electrolyte post-plug of 13.8 kPa (0.5 psi) for 5 s. All other conditions
were the same as those used in the pentasaccharide analyses.

In the patterning for Herceptin glycoprotein analyses, the capillary was first with 10%
nanogel buffered to Ph 7 with MOPS. An ECL plug was then introduced at 68.9 kPa (10
psi) for 7 s followed by an injection of 10% lipid spacer at 13.8 kPa (0.5 psi) for 7 s. For
the 30 cm capillary employed in this analysis, it took a plug of 2 aminobenzoic acid 70 s
to travel a distance of 20 cm when pushed at 10 psi by the 10% nanogel. A plug
introduced for 3.5 s would be 1 cm long. Therefore, lectin zone was 2 cm long. The UDPGal zone was then introduced at 68.9 kPa (10 psi) for 14 s (4 cm) followed by injection of
the enzyme plug at 68.9 kPa (10 psi) for 10.5 s (3 cm). A background electrolyte preplug of 13.8 kPa (2 psi) for 10 s was then introduced. The MnCl2 was included in the
anodic reservoir for the pre-separation step used to drive the substrate past the enzyme
plug. Sample injections were at 5 kV 4 s followed by a background electrolyte post-plug
of 13.8 kPa (0.5 psi) for 5 s. Reducing the velocity while passing through the enzyme
zone maximized enzyme conversion.25-27 Therefore, a pre-separation was performed, as
noted in each figure caption, in the beginning of the run to drive substrate through the
enzyme zone.
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3.3 Results and discusion
3.3.1 In-capillary asparagine linked glycan processing and separation.
To achieve the real-time N-glycan modification, the capillary was patterned as shown in
Figure 3.4A to ensure that both the donor and cofactor were present in the enzyme plug
when substrate was driven through the reaction zone. The manganese (II) cofactor was
incorporated in the enzyme plug and the plug on the anodic side of the enzyme zone.
This ensured that the cationic manganese (II) cofactor, which was at a concentration of 5
mM, was present when substrate reached the enzyme plug. The anionic donor, UDPgalactose, was patterned at a concentration of 5 mM in the enzyme zone and in a nanogel
zone on the cathodic side of the enzyme zone providing a constant supply of donor during
conversion. In addition, during the pre-separation, the cathodic reservoir contained 5 mM
UDP-galactose.

The remainder of the capillary was filled with the 10% nanogel to

facilitate the separation as previously described.25, 27, 30
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Figure 3.4 The process of in capillary
galactosyltransferase enzyme reaction.
Separation (A) The in-capillary patterning of the reaction
Reaction zone 9.5 cm
20.5 cm zones. The pentasaccharide residues are
represented with nomenclature defined by the
UDP-Gal GalT, MnCl2 MnCl2
UDP– Gal
Consortium for Functional Glycomics. (B)
Electropherogram showing the
pentasaccharide peak in the absence of
enzyme. (C) Electropherogram obtained in
the presence of 2 mU/L β1-4
B. Without enzyme
galactosyltransferase resulting in the addition
of one or two galactose residues. Separations
performed at 29 °C in a 25 µm i.d. capillary,
1mAu
with an effective length of 30 cm. A voltage of
20 kV for 1.5 min was used to drive
pentasaccharide to the beginning of the
reaction zone followed by mixing by polarity
cycling at 4 kV for 30 min (i.e. 6 min forward,
6 min reverse 6 min forward, 6 min reverse, 6
min forward). Separation was then done at
C. With enzyme
20 kV (reverse polarity). The reaction and
separation zone were suspended in 10%
nanogel with aqueous 100 mM MOPS
buffered to pH 7. Reproduced with
permission from: Bwanali, L.; Holland, L. A.,
Capillary Nanogel Electrophoresis for the
10.0
11.0
13.0
12.0
8.0
9.0
Time (min)
Determination of the β1-4
Galactosyltransferase Michaelis-Menten
Constant and Real-Time Addition of
Galactose Residues to N-Glycan and
Glycoprotein. Analytical Chemistry.
Submitted June 2021.

A. Capillary Reaction Zone

Nanogel separations were adapted so that the in-capillary modification with β1-4
galactosyltransferase was carried out in 100 mM MOPS buffered to pH 7 which was within
the working pH range of 6 to 9 recommended by the manufacturer. 38 The enzyme,
manganese zone and UDP-galactose zones were made in 10% nanogel. The enzyme
zone was patterned to be in the thermostable region of the capillary where temperature
was maintained at 29 °C.

This temperature was used because the manufacturer

recommended a reaction temperature of 30 °C38, and nanogel morphology was reported
to change above 29 °C.28 To improve conversion the substrate was driven through the
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enzyme zone at a low voltage of 4 kV as lower velocities ware previously demonstrated
to produce a more reproducible reaction and to enhance the conversion. 25-27 In addition,
polarity switching was used in which the voltage was programmed to migrate the
substrate in the forward and reverse directions for 5 passes through the 3 cm enzyme
zone, which created a longer effective length of the reaction zone and an estimated
reaction time of 30 min.

Pentasaccharide had two sites to which a galactose residue could have been transferred.
The degree of galactosylation was differentiated when the transferase enzyme reaction
was performed in-capillary and separated. The addition of a galactose monomer caused
a change in the charge-to-size ratio, which resulted in a shift in the migration time. The
pentasaccharide containing 0, 1, or 2 galactose residues migrated at 9.8, 10.8 and 11.6
minutes, respectively.

The capacity of the transferase enzyme to modify the

pentasaccharide substrate was observed by comparing the electropherograms obtained
in the absence (Fig 3.4B) and presence (Fig 3.4C) of enzyme. The conversion occurred
by repeatedly sweeping the substrate through a 3 cm zone of GalT at a concentration of
2 mU/L. Notably, the area of the agalactosylated pentasaccharide (39,000) observed in
the absence of enzyme (Fig 3.4B) was similar to the total peak area of the
agalactosylated, monogalactosylated, and digalactosylated pentasaccharide substrate,
which was 43,000 (Fig 3.4C).

These separations revealed that the distribution of

galactose residues was 39% agalactosylated, 49% monogalactosylated and 12%
digalactosylated.
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The mono and di-galactosylated peaks were broadened relative to the agalactosylated
peaks as observed in the peak width at half height of the unmodified substrate, which was
0.14 minutes, in comparison to the products, which were 0.27 minutes. Previous studies
have demonstrated the length of the reaction zone contributed to band broadening. 25, 27
The structural modification to the substrate changed the velocity in the electric field and
the arrival of the converted product was the sum of the velocity prior to and following the
enzymatic conversion. Therefore, substrate converted early in the enzyme zone had a
slightly different velocity from substrate converted later in the enzyme zone, which caused
peak broadening. These results demonstrated that the capillary electrophoresis method
provided a means to investigate the enzyme performance with knowledge of the product
formed.

3.3.2 KM determination of pentasaccharide glycan standard.
The power of the capillary electrophoresis method to both quantify and to distinguish
enzyme products was used to determine the enzyme Michaelis-Menten constant, KM,
which was measured by plotting the velocity of product formation against the substrate
concentration. For KM determinations the enzyme concentration was fixed for each
substrate concentration. The KM constant was 50% of the half-maximal velocity, which
required that the linear range of the detection method was compatible with product
concentrations to be measured. For an accurate measurement of the K M at least three
concentrations of substrate were analyzed at the point where velocity was changing
significantly and also at two concentrations near saturation. Less than 10% of the
substrate was converted to product. Unlike a benchtop reaction, where the velocity was
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determined by quenching the reaction at a specific time and reporting the concentration
of product formed per time; in an on-line system the velocity was a function of the
measured product concentration per migration time through the reaction zone.

A

calibration curve was used to convert the area of the product formed into concentration.
For the GalT enzyme-pentasaccharide reaction a prior report established the K M in the
mM range;42 therefore, the pentasaccharide substrate was labeled on the reducing end
with aminobenzoic acid which was detectable with UV absorbance. The concentration
range of the substrate detected with a 10 kV 10 sec injection was 25 M and 500 M.

With these parameters, the GalT enzyme concentration of 1 mU/L was chosen to limit
the GalT modification to the addition of a single galactose residue. At this concentration
the amount of the generated product remained within the linear range of the absorbance
detection without requiring in-capillary mixing. The substrate was driven through the
reaction zone at 4 kV and then separated in nanogel at 20 kV. No preliminary position
step was used for the KM study. Although a 4 kV 15 min pre-separation drive through
was used, the time for the reaction was 6 min based on the migration through a 3 cm
zone of enzyme embedded in a 9.5 cm pre-separation zone. As the starting and ending
position of substrate differed from the conditions used in Figure 3.4, the observed
migration time of the substrate and product differed. In the electropherogram in Figure
3.5 the product peak had more band broadening than the substrate peak, as was also
observed in the data in Figure 3.4. A range of pentasaccharide concentrations (i.e. 0.5,
0.75, 0.90, 1.23 mM) was analyzed as shown in Figure 3.5. Each substrate conversion
was measured in triplicate and calibration curves were run before and after the KM
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determinations.

The calibration curve is shown in

Figure 3.6.

For each data set

employed in the calibration curve, the line equation and associated error are shown in
Table 3.2, and the areas used to achieve each curve are shown in Table 3.3.
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A. Capillary Reaction Zone
Reaction zone 9.5 cm
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0.2mAu

8.0
6.0

7.0

8.0

Time (min)

9.0

8.5

9.0

9.5

10.0
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Figure 3.5 Determination of the Michaelis-Menten for the galactosyltransferase enzyme.
(A) (B) (C)The Michaelis-Menten curve generated by plotting the substrate concentration
versus the rate of product formation for pentasaccharide with 1 mU/L β1-4
galactosyltransferase in nanogel. Substrate concentrations were 0.50 mM, 0.75 mM, 0.90
mM, 1.00 mM, 1.23 mM, 2.00 mM, 3.00 mM and 4,00 mM. Pre-separation at 4 kV for 15
min to drive substrate past enzyme plug, and the separations were then performed at 20
kV. Capillary conditions were a temperature of 29 °C in a 25 um i.d. capillary with
effective length of 40 cm and E= 500 V/cm (reverse polarity). Reproduced with
permission from: Bwanali, L.; Holland, L. A., Capillary Nanogel Electrophoresis for the
Determination of the β1-4 Galactosyltransferase Michaelis-Menten Constant and RealTime Addition of Galactose Residues to N-Glycan and Glycoprotein. Analytical Chemistry.
Submitted June 2021.
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Figure 3.6 Calibration curve used to establish relationship between concentration and area.
Separations done without enzyme plugs. Separations conditions similar to Figure 3.2.
Reproduced with permission from: Bwanali, L.; Holland, L. A., Capillary Nanogel
Electrophoresis for the Determination of the β1-4 Galactosyltransferase Michaelis-Menten
Constant and Real-Time Addition of Galactose Residues to N-Glycan and Glycoprotein.
Analytical Chemistry. Submitted June 2021.
Table 3.2 Line equations and errors for 3 sets of data used to
achieve the calibration curve.

Set 1
Set 2
Set 3

Uncertainty Uncertainty in Y
in Slope
intercept
1000
300
900
300
700
200

Equation
y = 16000x + 700
y = 15900x + 700
y = 17900x + 400
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Table 3.3 Areas used to achieve the Calibration Curve.
Set1
Set 2
Set 3
Before KM
curve data
points

0.025mM
0.050mM
0.100mM
0.200mM
0.500mM

After KM
curve data
points

806
1374
2860

723
1279
2620
4302
8433

8428

After KM curve
data points

663
1040
2395
4262
9172

Peak areas of the product achieved with enzyme sequencing were converted to
concentration using this calibration curve constructed from an average of all
measurements.

The concentration was then converted to velocity with the known

reaction time (i.e. 6 min). The curve of velocity versus substrate concentration was fit
using nonlinear regression to obtain the KM (Fig 3.5). The KM value was determined as
1.26 ± 0.08 mM and VMAX as 0.073 ± 0.01 mM/min. The average KM and VMAX values
were achieved from averaging the values of the triplicate analysis in Figure 3.7. Peaks
were reproducible in area and time with relative standard deviations of 10% and 2% (n =
3), respectively (Table 3.4 and 3.5).
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Figure 3.7 The Michaelis-Menten curves showing reproducibility of method.
Data shows KM value achieved by plotting each data set individually. Reproduced
with permission from: Bwanali, L.; Holland, L. A., Capillary Nanogel Electrophoresis
for the Determination of the β1-4 Galactosyltransferase Michaelis-Menten Constant
and Real-Time Addition of Galactose Residues to N-Glycan and Glycoprotein.
Analytical Chemistry. Submitted June 2021.
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Table 3.4 Reproducibility in substrate peaks for n=3 runs used for
K M.
Time
Rsd
Area
Rsd
Concentration
µM

500
750
900
1230
2000
3000
4000

11.2
11.2
11.2
11.4
11.4
11.5
11.5

1
1
1
1
1
1
1

9,500
12,400
13,800
18,900
26,400
35,600
47,600

8
9
9
10
8
10
6

Table 3.5 Reproducibility in product peaks for n=3 runs used for
KM
Time
Rsd
Area
Rsd
Concentration
µM

500
750
900
1230
2000
3000
4000

11.9
12.0
11.9
12.2
12.2
12.3
12.4

1
1
1
1
1
1
2

1,300
1,800
2,000
2,300
2,700
3,200
3,400

10
4
2
5
3
3
3

The KM value obtained with the in-line capillary electrophoresis was statistically similar to
the

reported

reference

value

of

1.23

mM

for

pentasaccharide

and

β1-4

galactosyltransferase,42 as determined using a student’s t-test. Although the literature
method did not describe the degree of galactosylation, the capillary electrophoresis
method provided conclusive evidence that only a single galactose residue was transferred
to the pentasaccharide. This demonstrated the validity of the capillary electrophoresis
method and also drew attention to the ability of the method to confirm the product
associated with the measurement. Furthermore, in comparison to other methods used
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for KM determinations of GalT,42,

43

the automated capillary electrophoresis method

required less sample handling as there was no need for reaction quenching or purification
prior to detection. In addition, the capillary electrophoresis method consumed only a 15
nanoliter volume of enzyme in the 3 cm reaction zone, injected from a 5 µL vial solution,
making the method amenable to changing the in-line reaction to realize higher levels of
galactosylation; thereby, gaining insight into the process of galactose transfer..

3.3.3 Evaluating the addition of galactose residues to asparagine linked glycan.
Galactose transfer is relevant to N-glycans to understanding and harnessing GalT. To
demonstrate the mechanism of conversion relevant to glycoproteins, asparagine linked
glycan structures (i.e. N-glycans) were used as a substrate. The N-glycans, which were
from Herceptin, were analyzed at a higher enzyme:substrate ratio in order to observe the
process of galactose addition to a biantennary N-glycan which has two sites that can be
modified. In contrast to the pentasaccharide, which was labeled with aminobenzoic acid,
the N-glycans were labeled with APTS. The APTS enabled fluorescent detection of Nglycan at nanomolar substrate concentrations. As previously reported 33 the APTSlabeled Herceptin N-glycans are primarily agalactosylated with 77% of the N-glycans
lacking galactose and 23% composed of a single galactose residue based on analysis of
the peak areas in the electropherogram (see also Figure 3.8 and Tables 3.6 and 3.7).
The degree of galactosylation was distinguished by time as the agalactosylated N-glycan
peak (12.1 min, Fig 3.8A) had a larger charge-to-size ratio and migrated faster than the
monogalactosylated N-glycan peaks (13.1 min, Fig 3.8A). The peak identities were
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further confirmed by including the ECL lectin specific for galactose in the reaction zone
(Figure 3.9) which confirmed when the peaks contained 0,1, or 2 galactose residues.

Figure 3.8 Online modification of
glycans recovered from Herceptin.
Enzyme β1-4 galactosyltransferase is
in nanogel. When enzyme is not in
the capillary unmodified glycans are
distributed as shown in first trace.
Incorporating increasing enzyme
concentration demonstrated
conversion of the glycans.
Separations performed in a 25 µm i.d.
capillary, with an effective length of 50
cm and E=400 V/cm (reverse
polarity). All other conditions similar to
Figure 2. Differences in nanogel
composition in enzyme zones caused
slight shifts in runs. The migration
time marker denotated by the Asterix
was used to offset and align traces.
The offsets are as follows Trace A 0
min, Trace B 0.046 min, Trace C 0.158 min, Trace D -0.449 min, Trace
E 0.058 min and Trace F 0.099 min.
Reproduced with permission from:
Bwanali, L.; Holland, L. A., Capillary
Nanogel Electrophoresis for the
Determination of the β1-4
Galactosyltransferase MichaelisMenten Constant and Real-Time
Addition of Galactose Residues to NGlycan and Glycoprotein. Analytical
Chemistry. Submitted June 2021.
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Table 3.6 Area distribution of substrate and product with
changing enzyme concentration.
Area x10

3

Mono
Agalacto
galacto
digalacto
biantennary biantennary biantennary Total
mU Enzyme:
nmol Substrate
0 : 1
1.2 : 1
2.9 : 1
5.8 : 1
12 : 1
81 : 1

89
72
43
15

27
63
71
64
40

116
135
134
127
116
128

20
48
76
128

Table 3.7 % distribution of substrate and product with
changing enzyme concentration.
Mono
Agalacto
galacto
biantennary biantennary
mU Enzyme:
nmol Substrate
0 : 1
1.2 : 1
2.9 : 1
5.8 : 1
12 : 1
81 : 1

77
53
32
12
0
0

23
47
53
50
34
0
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digalacto
biantennary

0
0
15
38
66
100

Figure 3.9 Confirmation of online modification of glycans recovered from Herceptin with lectin.
5mU/µL β1-3,4 galactosyltransferase in nanogel was employed. When enzyme was not in the
capillary unmodified glycans were distributed as shown in Trace A. Incorporating Erythrina
Cristagalli galactosylated glycans were retarded (B). When enzyme was incorporated in the capillary
all glycans were converted to two galactose residues (C) which was confirmed by Erythrina
Cristagalli (D). Pre-separation was done at 4 kV for 15 min to drive substrate past enzyme plug. The
o
separations were then performed at 29 C in a 25 um i.d. capillary with effective length of 50 cm and
applied voltage of 20 kV (reverse polarity). Reproduced with permission from: Bwanali, L.; Holland,
L. A., Capillary Nanogel Electrophoresis for the Determination of the β1-4 Galactosyltransferase
Michaelis-Menten Constant and Real-Time Addition of Galactose Residues to N-Glycan and
Glycoprotein. Analytical Chemistry. Submitted June 2021.
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The process of transferring galactose to N-glycan was observed by increasing the
enzyme: substrate ratio in the reaction zone and quantifying the distribution of
galactosylation on the reaction products. As the reaction was performed in-line, the actual
amount of enzyme and substrate in the capillary was determined using the same units
employed by the vendor to define activity.40 The enzyme:substrate ratio was changed by
increasing the quantity of enzyme available for conversion while maintaining a fixed
amount of substrate of 1.3 picomoles.

This quantity of substrate in-capillary was

calculated44 based on the voltage, time, and capillary dimensions used for the
electrokinetic injection, with knowledge of the N-glycan mobility (i.e. 1.64x10-4 m2/Vs)
which was measured in the nanogel. A 10 kV for 10s injection into a 25 µm i.d. capillary
was performed from vial containing Herceptin N-glycans at a concentration of 100 nM.
The quantity of enzyme in-capillary was calculated based on flow injection analysis of the
velocity of the nanogel in Figure 3.10. A plug of APTS took 70 s when pushed with 10%
nanogel (at 10 psi) to travel a distance of 10.2 cm. The velocity of the nanogel at these
conditions is therefore 0.146 cm/s. Since the enzyme plug was pushed in for 21 s, the
distance of capillary filled was 3 cm, which translates to a volume of 15 nL injected into
the 25 µm i.d. capillary. To achieve five enzyme: substrate ratios, five injection vials with
different concentrations of enzyme of 0.1 mU/µL, 0.25 mU/µl, 0.5 mU/µL, 1 mU/µL and
7 mU/µL were utilized. The amounts of enzyme injected from each vial were calculated
to be 1.5 µU, 3.8 µU, 7.5 µU, 15 µU and 105 µU, leading to reaction enzyme:substrate
ratios of 1.2:1, 2.9:1, 5.8:1, 12:1 and 81:1 mU:nmol.
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Figure 3.10 . Flow injection analysis done by pushing APTS with 10% nanogel
The 60 cm capillary used for N-glycans analysis was filled with 10% nanogel at
10 psi. A plug of APTS was introduced using a 0.5 psi 5 s injection. The APTS
was then pushed a distance of 10.2 cm, to pass the detection window. The push
was performed with 10% the nanogel at 19 °C using a pressure of 10 psi.

The results of the in-line reactions performed at the five enzyme substrate ratios, shown
in Figure 3.8 traces B to F, demonstrated that the enzyme preferentially transfers a
galactose residue to one arm of the biantennary complex N-glycan. This preferential
addition of a galactose that is β1-4 linked on the N-glycan arm containing the N-acetyl-Dglucosamine that is α1-2 linked to D-mannose which is α1-6 linked to the innermost
mannose (Galβ1-4GlcNAcβ1-2Manα1-6Man) in the core structure has been reported
previously42 The peak denoted with the asterisk in Figure 3.6 was used as a migration
time marker to align the traces. Shifting in the migration time of the products was
attributed to differences in the nanogel composition of the enzyme zone. The peak areas,
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summarized in Table 3.6, ranged from 120,000 to 130,000 total N-glycan peak area
regardless of enzyme concentration. Only a single galactose residue was transferred
until the enzyme was increased to 2.9 mU/1 nmol of substrate, and 15% of the N-glycan
peak area was fully galactosylated (Table 3.7.). The amount of fully galactosylated Nglycan increased as the enzyme concentration was increased. At a ratio of 12 mU/1
nmol, the substrate peak was absent, and the product contained a distribution of 34%
mono and 66% di-galactosylated N-glycan. At a 81 mU/1 nmol ratio, the N-glycan was
fully converted to the di-galactosylated product.

These area distributions indicated that a single galactose residue was preferentially
added to the biantennary N-glycan. In a prior study, in the absence of the enzyme,
capillary nanogel electrophoresis distinguished the presence of a galactose on the 1,21,6-arm or the 1,2-1,3-arm.30 However, in the presence of enzyme, mono-galactosylated
peaks were obscured as seen in the traces in Figure 3.8. As previously noted, the
migration time and peak broadening reflected differences in velocity related to the location
within the enzyme zone that the conversion occurred.26

Additionally, transferase

enzymes have been reported to also function as hydrolases 45 further broadening the
product peak if galactose residues were both trimmed and extended in the reaction zone.
These studies confirmed that transferase enzymes could be integrated with capillary
electrophoresis. With this proof-of-principle established the method was adapted to
modify a glycoprotein.
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3.3.4 Application to glycoprotein.
The capillary electrophoresis enzyme nanogel reaction zones were modified for the
analysis of the Herceptin glycoprotein. The Herceptin was cationic, with an isoelectric
point of 9,46 therefore the patterning and separation were performed under conditions of
normal polarity. Thus, the order of patterning was reversed as compared to free Nglycans. The nanogel enzyme zone contained UDP-gal. As UDP galactose is anionic
and will migrate towards the anode, more of the donor was patterned to the right of the
enzyme zone as shown in Figure 3.11. The manganese is cationic and will migrate in a
similar direction as Herceptin (towards the cathode). In order to ensure a constant supply
of this cofactor during the modification, a concentration of 1 mM manganese (II) chloride
was maintained in the anodic vial used during the enzymatic conversion. A galactosespecific lectin, ECL, was positioned after the reaction zone because protein glycoforms
with different degrees of galactosylation did not have discernable mobilities.
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Figure 3.11 Online modification of glycan on
intact IgG1 glycoprotein.
In the absence of enzyme or lectin (A upper
trace) Herceptin separated into its charge
variants peaks with a the combined area of
590,000. Peak 1 is the basic variant of
Herceptin, peak 2 is the main peak and peaks
3 to 5 are the acidic variants. When lectin is
present, only the agalactosylated fraction of
Herceptin is detected (lower trace, area =
330,000). When enzyme is in the capillary, but
not lectin (B, upper trace) the total peak area is
560,000. When both enzyme and lectin are
present, no Herceptin is detected (B lower
trace) confirming the addition of galactose
residues. Thee plug contained 5 mU/µL GalT
and 1 mM UDP-Gal suspended in 10% nanogel
with 100 mM MOPS buffered to pH 7. The
lectin plug contained 100 µM ECL suspendered
in 10% nanogel. The 1 µM Herceptin was
electrokinetically injected (5 kV 4 s) and
detected with UV absorbance at 214 nm.
Separations were performed in a 25 µm i.d.
capillary, with an effective length of 10 cm and
applied voltage of 12 kV (E=400 V/cm, normal
polarity). A lower voltage was used for the
reaction (pre-separation at 4 kV for 26 min).
The separation and drive through were
performed in 10% nanogel buffered with
100mM pH 7 MOPS maintained at a
temperature of 20 °C. Reproduced with
permission from: Bwanali, L.; Holland, L. A.,
Capillary Nanogel Electrophoresis for the
Determination of the β1-4
Galactosyltransferase Michaelis-Menten
Constant and Real-Time Addition of Galactose
Residues to N-Glycan and Glycoprotein.
Analytical Chemistry. Submitted June 2021.

In the presence of the lectin, the addition of galactose was detected when the ECL-bound
Herceptin fraction was absent from the electropherogram.

The ECL lectin was

incompatible with the UDP galactose donor, and if patterned close together the galactose
from the donor would have bound to the lectin. To ensure lectin was available to bind
Herceptin glycoprotein only, and to reduce contamination with the donor, a nanogel
spacer was incorporated between the lectin and the donor. The reaction zones and
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separation were maintained at a pH of 7 in the 10% nanogel buffered to pH 7 with 100
mM MOPS.

At a separation temperature of 29 °C, which was used for the glycans, the

Herceptin glycoprotein mobility was reduced significantly and was not observed within a
30-minute separation.

Therefore, the separation temperature was lowered to 20 °C

where the gel was less viscous, and the mobility of the Herceptin in nanogel was 2.7x10 5

m2/Vs. By reducing the 30 cm effective length that was used for glycans to a 10 cm

effective length, the Herceptin separation was completed in 45 minutes if the field strength
was maintained at 400 V/cm. A lower electric field strength was used (133 V/cm) to drive
the Herceptin glycoprotein past the 3 cm enzyme plug. While no difference in lectin pull
down was observed for Herceptin when the enzyme: substrate was 5.8 mU enzyme/1
nmole (Figure 3.12), no agalactosylated N-glycan remained when free N-glycan was
subject to this ratio (Figure 3.8). To realize complete pull down of the Herceptin, which
required the presence of only a single galactose residue on one of the two biantennary
N-glycans in the hinge region, the amount of enzyme was increased above 12 mU
enzyme/1 nmole (Figure 3.12). These experiments revealed that the enzymatic transfer
of galactose was slower for intact glycoprotein. Therefore, to maximize the amount of
galactose transferred to the Herceptin glycoprotein the highest concentration GalT that
could be made, and the minimum concentration of Herceptin which was stable in solution
were used. This resulted in a ratio of 42 mU enzyme/1 nmole Herceptin N-glycan.
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Figure 3.12 Establishing the amount of modification at different enzyme to
substrate ratio as evidenced by lectin retardation of modified Herceptin.
Separation conditions are similar to Figure 3.8. Reproduced with permission
from: Bwanali, L.; Holland, L. A., Capillary Nanogel Electrophoresis for the
Determination of the β1-4 Galactosyltransferase Michaelis-Menten Constant
and Real-Time Addition of Galactose Residues to N-Glycan and
Glycoprotein. Analytical Chemistry. Submitted June 2021.

The enzymatic transfer of galactose residues to Herceptin glycoprotein was evaluated in
the presence and absence of enzyme and lectin. In the absence of enzyme and lectin
(Fig 3.11A, upper trace), the total area was 590,000, with a charge variant distribution as
previously reported.47 Peak one is the basic variant of Herceptin, peak 2 is the main peak
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and peaks 3 to 5 are the acidic variants.47 In the absence of enzyme but presence of
lectin (Fig 3.11A, lower trace), the lectin zone led to a 44% decrease in the Herceptin
peak area of 330,000 (i.e. 56% agalactosylated). This was anticipated as the Herceptin
N-glycan distribution (Fig 3.8 and Table 3.7.) revealed that the amount of N-glycans that
contained no galactose residues or one galactose residue, was 77% and 23%,
respectively. Assuming a random distribution, 60% of the Herceptin was expected to be
agalactosylated.

If the GalT enzyme successfully transferred galactose to the

glycoprotein, even more of the Herceptin would be retarded by the lectin zone. As shown
in Figure 3.8B, in the presence of the enzyme and lectin, no Herceptin peak was
observed, which confirmed that all Herceptin molecules had been modified with at least
one galactose residue. The shift in the Herceptin peak migration time in the presence of
enzyme was attributed to protein-protein interaction rather than a change in mobility
associated with the addition of galactose residues because when the Herceptin
separation was repeated in the presence of the enzyme, but with no UDP-gal donor or
manganese cofactor (Fig 3.13) the migration shift persisted. These data demonstrated
the utility of the capillary electrophoresis method for online enzyme modification of intact
glycoprotein.
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Figure 3.13 Confirmation that presence of enzyme
in capillary caused shifting of Herceptin peaks.
Separation conditions are similar to Figure 3.7.
Reproduced with permission from: Bwanali, L.;
Holland, L. A., Capillary Nanogel Electrophoresis
for
the
Determination
of
the
β1-4
Galactosyltransferase Michaelis-Menten Constant
and Real-Time Addition of Galactose Residues to
N-Glycan and Glycoprotein. Analytical Chemistry.
Submitted June 2021.

3.4 Conclusions and future directions
Nanogels enabled control over positioning and zone length of reactions integrated with
separations that were well suited for N-glycans and proteins. These nanogel zones were
employed to demonstrate on-line enzymatic transferase modification. The in capillary
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modification could distinguish the addition of one versus two galactose residues to
pentasaccharide as well as to biantennary N-glycan. A Michaelis-Menten constant of
1.26 mM was obtained for β1-4 galactosyltransferase and pentasaccharide using the
capillary electrophoresis method.

This KM value matched literature reported value.

Furthermore, the in-capillary enzymatic modification gave insight into the order of addition
of galactose. Finally, on-line transferase reaction was adapted to Herceptin glycoprotein,
demonstrating the utility of the method in modifying whole protein in real time.

Practical advantages of the capillary nanogel electrophoresis method include the low
volume (i.e. 15 nL) of enzyme required to modify the substrate. Additionally, the capillary
electrophoresis method was automated, and it did not require reaction quenching or
purification associated with offline reactions. This reduced the hands-on time required.
Finally, the time required to complete the enzyme reaction as well as the quantitative
analysis was less than 45 minutes.

The data achieved and the advantages of the in capillary enzymatic modification opens
avenues for further glycosyltransferase studies.

With the successful modification of

Herceptin glycoprotein, the approach will be expanded to other glycoproteins. Additional
benefits of the capillary nanogel electrophoresis method can be realized by applying it to
other transferase enzymes13, 14 and other enzyme classes. Finally, nanogels have been
shown to extend the lifetime of exoglycosidase enzymes. 26,

27

Additional studies will

determine the role of nanogel as a stabilizing medium for transferase enzymes.
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Chapter 4 Conclusions and Future Directions
4.1 Introduction
Capillary electrophoresis is a powerful tool for glycan analysis and modification, which
can be adapted to achieve real time complex reactions. In summary, this dissertation
illustrates how capillary electrophoresis was employed to carry out complex
exoglycosidase and transferase enzyme reactions to provide useful information about Nglycan sequence distribution and modification of glycoprotein online. Chapter 1 offered
background information from literature about N-glycan structures and current methods of
analysis, which include capillary electrophoresis.

Fundamentals of capillary

electrophoresis and how it is a versatile technique for N-glycans analysis was discussed.
Considerations in labeling with either a chromophore or fluorophore were outlined.
Analysis of N-glycans with enzymes and lectins in capillary electrophoresis for N-glycan
structural modification, identification and quantification was then outlined.

The serial enzyme sequencing in Chapter 2 showed the distribution of α2-6 linked sialic
acids in a tri-antennary standard and AGP samples. Phospholipid nanogel was used to
pattern the enzymes at the head of the separation capillary and sequentially cleave the
N-glycans, so that the presence of α2-6 linked sialic acids corresponded to a shift in the
analyte migration time in a manner that enabled interpretation of the N-glycan structure.
It was demonstrated that for the tri-antennary standard 0, 1,2, and 3 α2-6 linked sialic
acids were 4%, 59%, 36% and 2% which matched the vendor reported values. The
method was used to distinguish differences in α2-6 linked sialic acids in two samples of
AGP and provided new information of the distribution of these sialic acids on each branch.
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The most dominant form of α2-6 linked sialic acids in the two samples was only a single
α2-6 linked sialic acid on each branch. For the bi-antennary AGP sample one had 21%
as zero α2-6 linked sialic acids and 78% as 1 α2-6 linked sialic acids. AGP sample two
had 15% and 85% as 0 and 1 α2-6 linked sialic acids, respectively. For the tetraantennary sample 1 had 26% with 0 α2-6 linked sialic acids and 74% with one α2-6 linked
sialic acids. In contrast, sample two had 33%, 52%, 3% 8% and 3% as 0, 1, 2, 3, and 4
α2-6 linked sialic acids. correlated directly to the number of terminal galactose residues
that remained. The method is able to quantify α2-6 linked sialic acids on each branch
and identify differences in α2-6 linked sialic acids between samples.

Chapter 3 discussed how the thermally reversible nanogel is used in capillary
electrophoresis

to

create

discrete

regions

for

saccharide

modification

by

galactosyltransferase reaction and a subsequent separation of the substate and product.
The β1-4 galactosyltransferase enzyme, donor, and co-factor were patterned in the
capillary, and pentasaccharide substrate was driven through these zones and converted
to galactosylated products which were separated and identified.

The degree of

glycosylation was discernable for a pentasaccharide as well as for biantennary N-glycans.
With the ability to distinguish reaction products for which galactose addition resulted in a
single or two galactose residues, the capillary nanogel electrophoresis system was used
to determine the Michaelis-Menten value, KM. The KM for this β1-4 galactosyltransferase
was established to be 1.23 ± 0.08 mM for a pentasaccharide substrate. Once the K M was
established, the enzyme-to-substrate ratio was evaluated to add a single galactose
residue, or to fully galactosylated a biantennary N-glycan. Additionally, the method was

138

adapted to transfer galactose residues to protein. The applicability of the method for realtime online modification of whole protein was demonstrated with the Herceptin
glycoprotein.

Complete retardation by Erythrina Cristagalli lectin after enzymatic

modification confirmed addition of galactose to the Herceptin.

4.2 Future
4.2.1 Serial enzyme sequencing
Since sialic acids are labile

1, 2

and can be cleaved due to heat, storage or processing,

the serial enzyme processing method will be adapted to monitor the changes in the α2-6
linked sialic due to these processes. In preliminary findings, a sample of AGP was
analyzed for the change in the sialic acid distribution due to heat degradation. Three
reactions were incubated in 20 % acetic acid at 65 °C for 0, 3 and 6 hrs. The acetic acid
was used to mimic the APTS labeling conditions employed for N-glycans. As shown in
Figure 4.1, from this preliminary data, when the AGP N-glycans were analyzed without
enzymes it demonstrated that peaks close to 18 minutes start to decrease, while partially
desialylated peaks close to 20 minutes start to increase in intensity. When these samples
were analyzed with the multiple enzyme sequencing, Table 4.1, there was no significant
difference in the amount of the α2-6 linked sialic acid present for the 3 hrs compared to 0
hrs. This preliminary data suggests that the α2-3 linked sialic acid were degraded first,
therefore no change observed with the multiple enzyme sequencing. This result agrees
with literature findings that the α2-3 linked sialic acids are more readily cleaved than the
α2-6 linked sialic acids because of structural differences.2 As the incubation time was
increased to 6 hrs, lose in α2-6 linked sialic acid starts to be realized. This demonstrated
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the utility of the method to be utilized in demonstrating the impact of longer incubation
and storage.

Figure 4.1 Degradation of sialic acids dues to heat.
Electropherogram showing migration time shifts as more
sialic acids are lost from prolonged incubation. Separations
performed at 23 °C in a 25 µm i.d. capillary, with an
effective length of 50 cm and E=450V/cm (reverse polarity).
Separation is in 20% nanogel buffered with 50 mM pH 5
sodium acetate.
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Table 4.1 Relative abundance by area of α2-6
sialic acid of heat treated α-1-acid glycoprotein
asparagine-linked glycans.
3

α2-6 linked sialic acid area x10 (RSD)
Branch

Bi

Tri

0

1

2

3

4

Total

0 hrs 76(8)

310(5)

0

290(7)

0

6 hrs 120(7) 260 (7)

0

-

386(9)

3 hrs 80 (9)

-

0 hrs 230(4)

570(7)

0

0

3 hrs 250(5) 600(10)

0

0

6 hrs 300(6) 540(11)

0

0

-

370(11)
380(10)

800(8)
850(11)
840(13)

Tetra

0 hrs 210(9) 320(3) 16(9)
41(6)
15(7) 603(13)
3 hrs 190(4) 340(6) 13(10) 43(5)
0
586(13)
6 hrs 210(6) 310(1) 25(4)
40(6)
32(1) 617(9)
Solid lines in the table indicate that the structure not possible

4.2.2 Real-time in-capillary transferase reactions.
4.2.2.1 Application to other transferase reactions.
With knowledge of the in-capillary transferase modification the system will be applied to
other transferase enzymes.

With approximately 200 human wild type transferase

available3 and custom transferase enzymes being developed,4-6 this method is attractive
in characterizing transferase enzymes, as it has less sample handling involved.

In

addition, the method employs nanoliter volumes of reagent which makes it adaptable to
limited biological reagents.

With this knowledge, the applicability of the in-capillary

transferase modification was extended to obtain preliminary data with α2-3 sialyl
transferase enzyme. Similar to β1-4 galactosyl transferase, the α2-3 sialyl transferase is
also monomer specific and is used to attach α2-3 sialic acid to terminal galactose
residues. The donor substrate, cytidine-5′-monophospho-N-acetylneuraminic acid (CMPNeu5Ac), is needed to supply monomer for the transferase reaction. Addition of the
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neutral monomer galactose in the GalT reaction, caused a change in the size of the Nglycan, leading to product detected to the right of substrate. In contrast, sialic acids are
charged, and addition will lead to a change in both the size and net charge of the resultant
molecule.

This is observed as a migration time shift to the left of the product in

comparison to substrate.

Capillary patterning and separation conditions. Optimum working conditions for
enzymes were achieved by using the manufacturer recommended enzyme working pH
for separation, and by employing phospholipid nanogel to pattern the enzymes in the
capillary. The α2-3 sialyl transferase enzyme has an optimum working pH range of 7.5
to 8.5. The separation conditions were therefore tailored to be within this optimum
working range for the enzyme. The separation with and without enzyme modification, in
the addition of sialic acids, was done using sodium phosphate buffered to a pH of 8. At
lower pH than 7, the enzyme has been shown to act as a sialidase.7 The enzyme also
has some partial α2-6 sialyl transferase activity between pH 4-7.7 Enzyme activity for the
α2-3 sialyl transferase is not enhanced by the addition of divalent cofactors7 hence they
were not included in the separation. For patterning, a 1 cm plug of the enzyme and CMP
Neu5Ac in nanogel was pushed to the beginning of the thermostable region of the
capillary using a nanogel plug filled with CMP Neu5Ac. The rest of the capillary had been
filled with nanogel to enhance glycan separation.8-10 A temperature where the nanogel
has maximum viscosity to enhance separation, of 29 °C,11 was chosen for the analysis.
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The donor substrate migrates in a similar direction as the N-glycan and was therefore
patterned to ensure constant supply in enzyme plug during N-glycan modification. The
CMP Nue5Ac is anionic and at the separation condition It would migrate in the same
direction as analyte, towards the detector. Patterning was therefore done to ensure there
is donor substrate when the N-glycan reaches the enzyme plug.

Neu5Ac was

incorporated in the enzyme plug, in lipid push plug and in cathodic reservoir used when
driving N-glycan through enzyme plug.

Online sialic acid modification. Sialic acids modification of standard glycan was
achieved in real time using the sialyl transferase. As shown in Figure 4.2, the standard
galactosylated biantennary N-glycan was analyzed in a capillary with and without the
sialyl transferase enzyme.

Without the enzyme in the capillary the standard

galactosylated biantennary N-glycan peak migrates at 16.8 minutes.

When sialyl

transferase enzyme and CMP Neu5Ac were incorporated in the capillary α 2-3 sialic acids
were added to N-glycan giving rise to two products. All the initial substrate was modified
with α2-3 sialic acids with 30% (peak at 14.5 minutes) having one sialic acid and 70%
(peak at 13.3 minutes) having two sialic acids. Increasing the sialyl transferase enzyme
concentration could be used to ensure two sialic acids are added on every N-glycan. This
demonstrates the utility of the method to modify N-glycans in real time using an alternate
transferase enzyme
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Figure 4.2 Online reaction employing α23 sialyl transferase to modify standard
biantennary asparagine-linked glycan.
(A) Electropherogram showing the Nglycan peak in the absence of enzyme.
(B) Electropherogram obtained in the
presence of 1 mU/L α2-3 sialyl
transferase resulting in the addition of
one or two sialic acid residues.
Separations performed at 29 °C in a 25
µm i.d. capillary, with an effective length
of 60 cm. A voltage of 4 kV 15 min was
used to drive the substrate past the
enzyme plug. Separation was then done
at 20 kV (reverse polarity). The reaction
and separation zone were suspended in
10% nanogel with aqueous 50 mM
sodium phosphate buffered to pH 8.
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Reproducibility in the runs confirmed absence of non-specific adsorption or capillary
fouling by the enzyme. The total area was reproducible in the with and without enzyme,
meaning injections were not impacted by the presence of enzyme in the capillary. The
analysis without enzyme had an area of 40,000 (relative standard deviation of 9%) which
matched analysis with enzyme, total area of 41,000 (relative standard deviation of 3%).
The migration time relative standard deviation for the set without enzyme was 0.3% and
when enzyme was present it was 0.2% for the first peak and 3% for second peak.
Reproducibility in time showed that the enzyme was not fouling the capillary surface.
Plate count for analysis without enzyme was 590,000 and when enzyme was incorporated
it was 540,000 for first peak and 570,000 for second product peak. This confirmed that
there wasn’t any peak broadening in the capillary because of mass transfer. Conversion
for the sialyltransferase occurred over a shorter plug compared to the GalT, which
contributed to less broadening in the former.

This preliminary online conversion with α2-3 sialyl transferase demonstrates the
applicability of the online conversion with other transferase enzymes. In future work KM
of sialic acid addition for the α2-3 sialyl transferase can be demonstrated by monitoring
the kinetics of addition of the one sialic acid and two sialic acids. The method can further
be extended to demonstrate the difference in kinetics for the addition of α2-6 sialic acids
vs α2-3 sialic acids, with sialic acids of whole proteins also demonstrated online. With
the demonstration of both neutral and charged monomer addition completed this paves
a way for characterizing the addition of a different monomers in a single run. Future work
can also focus on the action of both wild type and mutant transferase enzymes.
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Adaptability of online transferase modification to different pH
Transferase enzymes have specific pH were activity is optimum 7,

12

decreasing or exoglycosidase activity observed at different pH values.7

with activity
The online

transferase modification is adaptable to characterize the transferase enzyme at different
pH values. If more than one transferase enzyme is to be patterned in the capillary, this
may require the discrete enzyme zones to be patterned at pH values optimum for each
individual enzyme. Having discontinuous pH zones in the capillary enables patterning
the enzyme zone at conditions for optimum reaction and setting the separation conditions
to maximize efficiency in enzyme catalysis.

To demonstrate the applicability of the online transferase modification to different pH
values, the data in Figure 3.7 was first repeated with an agalactosylated standard
biantennary N-glycan utilizing similar conditions as Figure 3.7. The results of this analysis
are shown in Figure 4.3. When lectin was incorporated in the capillary, without enzyme,
the migration time, and the area of biantennary N-glycan (Figure 4.2B) matched that of
the blank (Figure 4.2A) confirming no galactose residues present added. When the
enzyme was incorporated in the capillary, the N-glycan was modified, and a new peak
appeared at 14.4 minutes (Fig 4.4C). The complete modification was confirmed by
incorporating lectin in the capillary and the peak disappeared from the electropherogram.
The same analysis was repeated at a different pH with a different buffer to confirm
enzyme activity. Analysis was done with a 10% nanogel buffered with 100 mM MES pH
6.5 as shown in Figure 4.4. When the enzyme was present in the capillary the agalacto
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biantennary N-glycan was modified to two galactose residues. Herceptin N-glycans
analyzed under these conditions also demonstrated complete conversion as shown in
Figure 4.5. These preliminary data demonstrate that when the pH is within the working
range of the enzyme complete modification is achieved. Future studies can focus on
repeating the analysis at pH values outside the working range. This will open avenues
for rapid method to characterize the optimum working range of the transferase enzymes.
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Figure 4.3 Online modification of standard agalacto biantennary asparagine-linked
glycan in 3-(N-morpholino)-propanesulfonic acid pH 7.
Enzyme concentration is 2 mU/µL β1-3,4 galactosyltransferase in nanogel. When
enzyme is not in the capillary unmodified glycans are distributed as shown in Trace
A. No response is observed to Erythrina Cristagalli confirming no galactose
residues present (B). When enzyme is incorporated in the capillary the N-glycan
is converted to two galactose residues (C) which is confirmed by Erythrina
Cristagalli (D). Separations condition similar to Figure 3.7. The Asterix denotes
contaminant peaks. These contaminants did not respond to lectin or enzyme.
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Figure 4.4 Online modification of standard
agalacto biantennary glycan in 2-(N-Morpholino)
ethanesulfonic acid pH 6.5.
Enzyme concentration is 2 mU/µL β1-3,4
galactosyltransferase in nanogel. When enzyme
is not in the capillary unmodified glycans are
distributed as shown in upper trace. When
enzyme is incorporated in the capillary the Nglycan is converted to two galactose residues as
shown in lower Trace. Separation is in 10%
nanogel buffered to pH 6.5 with 100mM MES.
Separations are performed at 20 kV, 29 °C in a
25 µm i.d. capillary with effective length of 50 cm.
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Figure 4.5 Online modification of Herceptin asparagine-linked glycans in
2-(N-Morpholino) ethanesulfonic acid pH 6.5.
Enzyme concentration is 2 mU/µL β1-3,4 galactosyltransferase in
nanogel. When enzyme is not in the capillary the unmodified glycans are
distributed as shown in upper trace. When enzyme is incorporated in the
capillary the N-glycans are converted to two galactose residues as
shown in lower Trace. All other separations conditions similar to Figure
4.4.
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Adaptability of online transferase modification when enzymatic conversion and
separation pH are different.
To demonstrate the applicability of the method using discontinuous zones, the capillary
electrophoresis enzyme nanogel reaction zones were modified for the analysis of the
Herceptin glycoprotein.

Patterning, as demonstrated in figure 4.6, was achieved to

ensure the reaction occurs at optimum conditions for the enzyme but separation is done
at conditions that improve efficiency. Since the Herceptin is cationic, the patterning and
separation were maintained under conditions of normal polarity. Nanogel was employed
only for the enzyme zone with the UDP-gal plug, manganese (II) chloride zone, lectin
zone and separation zone made from aqueous buffers.

The UDP galactose zone,

manganese (II) chloride and the lectin zone were reconstituted in aqueous MOPS
buffered to a pH of 7. The reaction zone was maintained at a pH of 7 in the 10% nanogel
as had been demonstrated in Figure 3.7, but the separation was performed in an aqueous
solution of 50 mM sodium acetate solution buffered to pH 5 because Herceptin mobility
is higher at pH 5 (9.4 x10-5 cm2/vs). This allowed the drive through and separation to be
accomplished in a 30 cm effective length separation with similar analysis time as in Figure
3.8, which utilized 10 cm effective length.
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A. Without Enzyme/Without Lectin
Blank

MnCl2

UDP- Gal

Blank

Figure 4.6 Modification of intact Herceptin
glycoprotein when enzymatic conversion
pH is different to separation pH.
Separation without enzyme or lectin
shows the Herceptin peaks (A). In the
absence of enzyme or lectin the protein
charge variants are separated. When
lectin is present only the galactosylated
fraction is retarded (B). Incorporating
enzyme in capillary modifies glycans on
Herceptin (C) which is confirmed by
complete retardation of Herceptin when
both enzyme and lectin are in the
capillary (D). Herceptin with a
concentration of 1 µM was
electrokinetically introduced in the
capillary by a 2 kV 2 second injection.
Detection was performed at 214nm.
Separations performed in a 25 µm i.d.
capillary, with an effective length of 20
cm and E=400 V/cm (normal polarity).
Pre-separation at 2 kV for 12 min to drive
substrate past enzyme plug. Enzyme
concentration is 5 mU/L β1-4
galactosyltransferase suspended in 10%
nanogel with 100 mM MOPS buffered to
pH 7. Separation BGE does not contain
nanogel and is aqueous 50 mM sodium
acetate buffered to pH 5.

Separation

5mAu

B. With Enzyme/Without Lectin
MnCl2

GalT,MnCl2 UDP- Gal
UDP- Gal

Blank
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C.. Without Enzyme/With Lectin
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MnCl2

UDP- Gal

Lectin Separation

D. With Enzyme/With Lectin
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10.0

GalT,MnCl2 UDP- Gal
UDP- Gal

12.0

14.0

16.0

Lectin Separation

18.0

20.0

Time (min)
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An enzyme: substrate ratio of 67:1 was maintained for the modification. When enzyme
was included in the reaction zone and galactose residues were transferred to the
glycoprotein, no shift in the peak migration pattern was observed (Fig 4.6 A, B). This was
because the relative increase in mass of the Herceptin (MW ~ 150 kDa) was negligible
and had little effect on the charge-to-size ratio. The effectiveness of the enzymatic
modification was observed by including the galactose specific ECL lectin in the reaction
zone. In the absence of enzyme (Fig 4.6 C), the lectin zone led to a decrease in the
Herceptin peak area of 50%. In the presence of the enzyme and lectin zones (Fig 4.6 D),
no Herceptin peak was observed, which confirmed that all Herceptin molecules had been
modified with at least one galactose residue. These data demonstrated the utility of the
capillary electrophoresis method for online enzyme modification when enzymatic
conversion pH is different to separation pH. This knowledge can be employed when the
separation and the reaction conditions need to be different.

Online Fluorescence labeling of Glycoprotein
Fluorescence labeling of the glycoprotein will translate to lower amount utilized in the
analysis. This is desirable as it will increase the enzyme to substrate ratio in the capillary.
Furthermore, this approach is useful for limited glycoprotein samples quantities.
Preliminary experiments have been done to label the Herceptin online using Alexaflour
488 tagged Protein G.
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Protein G is a 22 KDa bacterial protein that binds to IgGs.13, 14 The binding constant is in
the picomolar level and the binding is optimum between pH of 4 and 5.14, 15 The isoelectric
point of Protein G is 4.514 and in a separation buffer at a pH of 5 Protein G will be anionic.
A 30 cm total length capillary, with 10 cm effective length from the cathodic side to the
detector was utilized to analyze Protein G by itself. For the separation and detection, the
capillary was patterned as demonstrated in Figure 4.7. Protein G was injected from the
cathodic side and the profile demonstrated in Figure 4.7 was observed.

Figure 4.7 Separation of Alexaflour 488 labeled Protein G.
The protein G was injected on the cathodic side of the
capillary. Injection is 2 kV for 2 s. Separation is performed
in a 25 µm i.d. capillary, with an total length of 30 cm and
10 cm from the cathodic side to detector. E=400 V/cm
(normal polarity). Separation is aqueous 50 mM sodium
acetate buffered to pH 5.
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To demonstrate the online labeling of Herceptin with Protein G the capillary was set up
as show in Figure 4.8. Sodium chloride was incorporated in the separation to reduced
non-specific interaction of the proteins with the column surface.

Aggregates were

observed as spikes in the electropherogram when sodium chloride was absent in
background electrolyte. A dual opposite injection was utilized to introduce Herceptin and
Protein G simultaneously in the capillary. Since the Herceptin is cationic at pH of 5 it was
injected from the anodic side. The Protein G is anionic and was injected from the cathodic
side. The Protein G has a higher mobility and has shorter distance to pass the detector,
therefore the unbound Protein G peak was observed as the first peak. After passing the
detector the Protein G was bound to the Herceptin. The higher charge to size ratio of
Herceptin compared to Protein G dictated that the mobility of the Herceptin dominated
the mobility complex. The labeled Herceptin was detected as a peak at 10 minutes. The
position of the complex formation, and therefore the time it appears in electropherogram,
was changed by changing the time Herceptin is injected in the capillary. If Herceptin was
injected when Protein G had been pre-separated in the capillary, the complex would shift
to faster times. In order to achieve reproducible separations a more rigorous flush
between runs was introduced to strip any adsorbed protein from the capillary surface.
This flush included 7.5 minutes of methanol 5 minutes of water, 7.5 minutes of base, 7.5
minutes of buffer, 20 minutes of coat and 5 minutes of buffer. This demonstrated the
utility of the method of fluorescently label the Herceptin online before the transferase
reaction. The principle is also applicable to identifying IgGs in complex mixtures

155

Figure 4.8 Online labeling of Herceptin with Alexaflour 488 tagged Protein G.
The Protein G was injected on the cathodic side and the Herceptin on the
anodic side of the capillary. Injection is done at 2 kV for 2 s. Separation is
performed in a 25 µm i.d. capillary, with an total length of 30 cm and 10 cm
from the cathodic side to detector. E=400 V/cm (normal polarity). Separation
is aqueous 50 mM sodium acetate buffered to pH 5 containing 40 mM sodium
chloride.
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4.3 Future directions
The preliminary data for both the online serial enzyme sequencing and the transferase
enzyme modification demonstrated the possibility of extending the work reported in
Chapter 2 and 3. The preliminary data in analyzing heat degraded samples with serial
enzyme digestion demonstrated the method can be used to analyze heat or age degraded
samples.

Initial findings with α2-3 sialyl transferase data demonstrated that the online

transferase modification can be extended to other glycosyltransferase enzymes.
Furthermore, data in this chapter showed adaptability of method to different pH values.
Online labeling of Herceptin with Protein G was demonstrated which opens avenues for
increasing the enzyme to substate ratio for the transferase reactions.
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Appendix

Figure A-1. Migration time shifts based on the number of terminal galactose
residues present in in a biantennary standard N-Glycan after serial enzyme
processing. Data associated with Figure 2.2B.
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Figure A-2. Verification of the serial enzyme processing for the biantennary
standard N-Glycan using α2-3 sialidase. Data associated with Figure 2.2C.
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Figure A-3. Electropherograms achieved with 750 µUnits/µL of α2-3 sialidase in
the enzyme range study for the biantennary standard N-Glycan. Data associated
with Figure 2.3A.
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Figure A-4. Electropherograms achieved with 250 µUnits/µL of α2-3 sialidase in
the enzyme range study for the biantennary standard N-Glycan. Data associated
with Figure 2.3B.
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Figure A-5. Electropherogram achieved with 250 µUnits/µL of α2-3 sialidase plus
MAL lectin in the enzyme range study for the biantennary standard N-Glycan. Data
associated with Figure 2.3C.
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Figure A-6. Electropherograms achieved with 5 µUnits/µL of α2-3 sialidase in the
enzyme range study for the biantennary standard N-Glycan. Data associated with
Figure 2.3D.
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Figure A-7. Serial enzyme sequencing reference trace with α2-3,6,8 sialidase for
AGP sample 1. Data associated with Figure 2.4A black trace.
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Figure A-8. Serial enzyme sequencing reference trace with α2-3,6,8 sialidase and
β1-3,4 galactosidase for AGP sample 1. Data associated with Figure 2.4A blue
trace.
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Figure A-9. Serial enzyme sequencing of AGP sample 1 in the absence of ECL.
Data associated with Figure 2.4B black trace.
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Figure A-10. Serial enzyme sequencing of AGP sample 1 in the presence of ECL.
Data associated with Figure 2.4B blue trace.
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Figure A-11. Electropherograms achieved with 750 µUnits/µL of α2-3 sialidase in

the enzyme range study for AGP sample 1. Data associated with Figure 2.5 first
trace.
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Figure A-12. Electropherograms achieved with 250 µUnits/µL of α2-3 sialidase in
the enzyme range study for AGP sample 1. Data associated with Figure 2.5
second trace.
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Figure A-13. Electropherograms achieved with 250 µUnits/µL of α2-3 sialidase
plus MAL in the enzyme range study for AGP sample 1. Data associated with
Figure 2.5 third trace.
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Figure A-14. Electropherograms achieved with 50 µUnits/µL of α2-3 sialidase in
the enzyme range study for AGP sample 1. Data associated with Figure 2.5 fourth
trace.
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Figure A-15. Electropherograms achieved with 750 µUnits/µL of α2-3 sialidase in
the enzyme range study for AGP sample 2. Data associated with Figure 2.6 first
trace.
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Figure A-16. Electropherograms achieved with 250 µUnits/µL of α2-3 sialidase in
the enzyme range study for AGP sample 2. Data associated with Figure 2.6
second trace.
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Figure A-17. Electropherogram achieved with 250 µUnits/µL of α2-3 sialidase plus
MAL in the enzyme range study for AGP sample 2. Data associated with Figure
2.6 third trace.
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Figure A-18. Electropherogram achieved with 250 µUnits/µL of α2-3 sialidase plus
MAL in the enzyme range study for AGP sample 2. Data associated with Figure
2.6 fourth trace.
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Figure A-19. Serial enzyme sequencing reference trace with α2-3,6,8 sialidase for
AGP sample 2. Data associated with Figure 2.7A black trace.
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Figure A-20. Serial enzyme sequencing reference trace with α2-3,6,8 sialidase

and β1-3,4 galactosidase for AGP sample 2. Data associated with Figure 2.7A
blue trace.
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Figure A-20. Serial enzyme sequencing reference trace with α2-3,6,8 sialidase
and β1-3,4 galactosidase for AGP sample 2. n=3 of Figure 2.7A blue trace.
Figure A-21. Serial enzyme sequencing of AGP sample 2 in the absence of ECL.
Data associated with Figure 2.7B black trace.
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Figure A-22. Serial enzyme sequencing of AGP sample 2 in the presence of ECL.
Data associated with Figure 2.7B blue trace.
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Figure A-23. Electropherograms of the pentasaccharide in the absence of GalT
enzyme.

Data associated with Figure 3.4B
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Figure A-24. Electropherograms of the pentasaccharide in the presence of 2 mU/µl
GalT enzyme. Data associated with Figure 3.4C
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4.00 mM

3.00 mM

2.00 mM

1.23 mM

0.90 mM

0.75 mM

0.5 mM

Figure A-25. Set 1 of electropherograms of the pentasaccharide used to achieve
KM curve.

Data associated with Figure 3.5 and Figure 3.7
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4.00 mM

3.00 mM

2.00 mM

1.23 mM

0.90 mM

0.75 mM

0.5 mM

Figure A-26. Set 2 of electropherograms of the pentasaccharide used to achieve
KM curve.

Data associated with Figure 3.5 and Figure 3.7
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4.00 mM

3.00 mM

2.00 mM

1.23 mM

0.90 mM

0.75 mM

0.5 mM

Figure A-27. Set 3 of electropherograms of the pentasaccharide used to achieve
KM curve.

Data associated with Figure 3.5 and Figure 3.7

186

0.500 mM

0.100 mM

0.050 mM

0.025 mM

Figure A-28. Set 1 of electropherograms of the pentasaccharide used to achieve
the calibration curve.

Data associated with Figure 3.6
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0.500 mM

0.200 mM

0.100 mM

0.050 mM

0.025 mM

Figure A-29. Set 2 of electropherograms of the pentasaccharide used to achieve
the calibration curve.

Data associated with Figure 3.6
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0.500 mM

0.200 mM

0.100 mM

0.050 mM

0.025 mM

Figure A-30. Set 3 of electropherograms of the pentasaccharide used to achieve
the calibration curve.

Data associated with Figure 3.6
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Figure A-31. Electropherograms shing addition of galactose residues to N-glycans
recovered from Herceptin. Data associated with Figure 3.8
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Blank Blank

Enzyme Blank

Blank ECL

Enzyme ECL

Figure A-32. Electropherograms showing confirmation of GalT modification with
ECL of N-glycans recovered from Herceptin. Set 1 of data associated with Figure
3.9
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Blank Blank

Enzyme Blank

Blank ECL

Enzyme ECL

Figure A-33. Electropherograms showing confirmation of GalT modification with
ECL of N-glycans recovered from Herceptin. Set 2 of data associated with Figure
3.9
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Blank Blank

Enzyme Blank

Blank ECL

Enzyme ECL

Figure A-34. Electropherograms showing confirmation of GalT modification with
ECL of N-glycans recovered from Herceptin. Set 3 of data associated with Figure
3.9
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Blank Blank

Blank ECL

Enzyme Blank

Enzyme ECL

Figure

A-35.

Electropherograms

showing

GalT

glycoprotein. Set 1 of data associated with Figure 3.11
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modification

Herceptin

Blank Blank

Enzyme Blank

Blank ECL

Enzyme ECL

Figure

A-36.

Electropherograms

showing

GalT

glycoprotein. Set 2 of data associated with Figure 3.11
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modification

Herceptin

Blank Blank

Enzyme Blank

Blank ECL

Enzyme ECL

Figure

A-37.

Electropherograms

showing

GalT

glycoprotein. Set 3 of data associated with Figure 3.11
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modification

Herceptin

Enzyme : substrate calculation for N-glycan
Flow injection 70 s to cover 10.2 cm
Velocity 0.146 cm per sec
Injection 21 s which translates to 3.1 cm
2
volume
= πr h
-6
2
=[π x (12.5x10 m) x 0.0031 m
-12
= 15.2 10 m
-9
=15.2 x10 L =15 nL
For the lowest concentration 15 nL x 0.1 mU/µL
= 15 nl x 0.1 µU/nL
=1.5 µL
Enzyme concentration vial Amount in capillary
-6
0.1 mU/µlL
1.5x10 U
-6

0.25 mU/µL

3.8x10 U

0.5 mU/µL

7.5x10 U

1 mU/µL

15x10 U

7 mU/µL

105x10 U

-6

-6

-6

QN-glycan =[πr2 μVt/L][Ci]
μ= (60x50)/(15.3x60x20,000) =1.64x10 -4
-6
2
=[π x (12.5x10 m) 10,000 x 1.64x10-4 x10s /6x10-1 m][Ci]
=[8.1 x 10-9/6x 10-1m][Ci]
=13.4 x 10-9 m3 [Ci]
=13400 x 10-12 m3 [Ci]
(13400 x 10-9 L injected)
=13400 x 10-9 l [100 x 10-9 moles/L)
=1.34 x10-12 moles = 1.34 picomoles
[Enzyme]

Amount in capillary

0.1 mU/µL

1.5x10 U

0.25 mU/µL

3.8x10 U

0.5 mU/µL

7.5x10 U

1 mU/µL

15x10 U

7 mU/µL

105x10 U

-6
-6
-6

-6

-6

Ratio enzyme to
substrate
6
1.2 x10 U E: 1 mole S 1.2 mU E: 1 nmole S
6
2.9 x10 U E: 1 mole S 2.9 mU E: 1 nmole S
6
5.8 x10 U E: 1 mole S 5.8 mU E: 1 nmole S
6
12 x10 U E: 1 mole S 12 mU E: 1 nmole S
6

81 x10 U E: 1 mole S
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81 mU E:1 nmole S

Calculation of enzyme to substrate ratio for Herceptin glycoprotein
Flow injection 70 s to cover 20 cm
Velocity 0.286cm per sec
Injection 10.5 s which translates to 3 cm
2
volume
= πr h
-6
2
=[π x (12.5x10 m) x 0.03 m
-12
= 14.7 10 m
-9
=14.7x10 L =15 nL
Amount in capillary for lowest concentration = 15 nL x 0.345 mU/µL
= 15 nL x 0.345 µU/nL
= 0.345 µU = 5.2 µU
Enzyme concentration vial
0.345 mU/µL

Amount in capillary

0.690 mU/µL

10.4x10 U

1.13 mU/µL

17x10 U

1.38 mU/µL

21x10 U

5 mU/µL

75x10 U

-6

-6
-6
-6

2

Qherceptin =[πr μappVinttint/L][Ci]
-6

-6

5.2x10 U

-5

2

μapp= (30x10)/(15.8 x60x12,000) =2.7x10 m /Vs

2

-5

-1

=[π x (12.5x10 m) x 5,000 x 2.7 x10 x4s /3x10 m][Ci]
-10

-1

=[2.7 x 10 /3x 10 m][Ci]
=9 x 10

-10

=900 x 10

3

m [Ci]
-12
-9

3

m [Ci]
-6

=900 x 10 l [1 x 10 moles/L)
=9E-13 moles
with 2 glycans per her 1.8 picomoles glycan
[Enzyme]

Amount in capillary

0.345 mU/µL

5.2x10 U

0.690 mU/µL

10.4x10 U

1.13 mU/µL

17x10 U

1.38 mU/µL

21x10 U

5 mU/µL

75x10 U

-6

-6

-6
-6
-6

Ratio enzyme to
substrate
6
2.9 x10 U E: 1 mole S 2.9 mU E: 1 nmole S
6
5.8 x10 U E: 1 mole S 5.8 mU E: 1 nmole S
6
9.5 x10 U E: 1 mole S 9.5 mU E: 1 nmole S
6
12 x10 U E: 1 mole S 12 mU E: 1 nmole S
6
42 x10 U E: 1 mole S 42 mU E: 1 nmole S
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Migration time 1.17 minutes

Figure A-38 . Flow injection analysis done by pushing APTS with 10% nanogel
The 30 cm capillary used for Herceptin glycoprotein analysis was filled with 10%
nanogel at 10 psi. A plug of 2AB was introduced using a 0.5 psi 5 s injection.
The 2AB was then pushed a distance of 20 cm to pass the detection window.
Push performed with 10% nanogel at 19 °C using a pressure of 10 psi.
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